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ABSTRACT 
 
Nectin-1 is Degraded in Chlamydia trachomatis-infected Genital Epithelial Cells and is 
Required for Herpes Simplex Virus Co-infection-induced C.trachomatis Persistence 
 
By 
 
Jingru Sun 
 
The obligate intracellular bacterium Chlamydia trachomatis is the most common 
bacterial STD agent in the US. This bacterium has a unique biphasic developmental cycle 
in which the infectious elementary body (EB) infects a host mucosal epithelial cell and 
differentiates into the replicative form (the reticulate body or RB) within a modified 
vacuole called an inclusion. The RB later divides and develops back into an EB and is 
released, perpetuating the infectious cycle. When developing chlamydiae are exposed to 
unfavorable environmental conditions, they deviate from the normal developmental cycle 
into a non-infectious but viable state termed persistence. Previous data from our 
laboratory indicate that i) during C. trachomatis/HSV co-infection, the chlamydiae 
become persistent and ii) HSV gD interaction with host cell surface is sufficient to induce 
this response. During viral entry, HSV gD interacts with one of four host co-receptors, 
one of which is the host adhesion molecule nectin-1. Interestingly, Western blotting 
demonstrated that nectin-1 is significantly decreased in C. trachomatis-infected HeLa 
cells. Additional studies indicated that active C. trachomatis replication is required for 
nectin-1 down-regulation and nectin-1 is likely down-regulated post-translationally. 
CPAF, a chlamydia-secreted protease, is responsible for degrading several host proteins. 
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Both in vivo experiments using CPAF-specific chemical inhibitors and cell-free cleavage 
assays using recombinant CPAF indicate that nectin-1 is degraded by CPAF in C. 
trachomatis-infected cells. Further studies suggest that nectin-1 is the most likely 
candidate involved in triggering HSV-induced chlamydial persistence. Co-infection 
experiments using nectin-1-specific HSV-1 mutants suggest that nectin-1 is, indeed, 
required for persistence induction. Additional studies in single co-receptor-expressing 
CHO cells demonstrate that, despite the fact that HSV-1 enters both HVEM- and nectin-
1-expressing cells, viral co-infection reduces chlamydial infectivity only in the CHO-
nectin-1 cell line. These data confirm that HSV/nectin-1 interaction is sufficient for 
chlamydial persistence induction. Although nectin-1 ligation is known to activate Cdc42, 
pull-down assays indicate that Cdc42 is not activated in co-infected HeLa cells. Taken 
together, these data suggest that: i) HSV gD-nectin-1 binding activates a novel host 
epithelial cell pathway that restricts chlamydial development and ii) the chlamydiae may 
degrade nectin-1 to evade this inhibitory host response. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 4
DEDICATION 
 
This manuscript is dedicated to my husband Dr. Yiyong Liu. Thank you for 
always being there to support me. Thank you for always encouraging me to never give up 
on my dreams. Thank you for always inspiring me to aim high and accomplish.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 5
ACKNOWLEDGEMENTS 
 
First, and foremost, I would like to thank my advisor Dr. Robert Schoborg for his 
help and support over the past several years. Without his constant guidance and teaching, 
I would not have been able to accomplish my Ph. D study. The working experience with 
him was wonderful and priceless. I will be forever grateful to him for all that he taught 
me in the lab and in life.  
 
I would also like to thank Dr. Jennifer Vanover (Jenny) and Ms. Jennifer Kintner 
(Jen) for being wonderful lab coworkers and friends. I am deeply grateful for their 
constant help and encouragement. My wonderful experience in the lab wouldn’t have 
been the same without them.  
 
I would also like to thank my graduate committee members, Dr. Priscilla Wyrick, 
Dr. Dennis Defoe, Dr. Russell Hayman, and Dr. Douglas Thewke for their time, advice, 
encouragement, and excellent guidance throughout my graduate study.  
 
I am very grateful to Dr. Michelle Duffourc and Dr. John Laffan for their endless 
help and support. I am also grateful to the Biomedical Sciences Program and the 
Department of Microbiology for all the help and financial support.  
 
Finally, I would like to thank my family. Special thanks go to my parents, 
Rongmin Sun and Aixia Nan, for their unconditional love and support. They always 
encourage me to pursue my dreams.  Also, I would like to thank my sister, Huijing Sun, 
for her constant support and encouragement, and always being there to talk.  
 
This work was supported by NIH grant #5R21AI59563, ETSU RDC grant #04-
024M awarded to Robert V. Schoborg, and an ETSU Graduate Council research grant 
awarded to Jingru Sun.  
 
 
 
 6
CONTENTS 
 
 Page 
ABSTRACT .......................................................................................................................... 2 
DEDICATION ...................................................................................................................... 4 
ACKNOWLEDGEMENTS .................................................................................................. 5 
LIST OF FIGURES .............................................................................................................. 10 
LIST OF TABLES ................................................................................................................ 11 
 
Chapter 
 1. INTRODUCTION ......................................................................................................... 12 
Chlamydia trachomatis .............................................................................................. 12 
The Chlamydial Developmental Cycle................................................................ 13 
Chlamydial Persistence........................................................................................ 15 
Chlamydia Protease-like Activity Factor (CPAF) ..................................................... 18 
Nectins ....................................................................................................................... 20 
Herpes Simplex Virus (HSV) .................................................................................... 22 
HSV and C. trachomatis Co-infection....................................................................... 27 
Summary of Previous Co-infection Studies from Our Laboratory............................ 28 
Questions to be Answered in the Studies................................................................... 30 
 2. THE HOST ADHERENS JUNCTION MOLECULE NECTIN-1 IS DOWN-
REGULATED IN CHLAMYDIA TRACHOMATIS-INFECTED GENITAL 
EPITHELIAL CELLS ................................................................................................. 32 
Summary .................................................................................................................... 33 
Introduction................................................................................................................ 34 
Methods...................................................................................................................... 36 
 Cell Culture, Chlamydial Infection and Titrations .............................................. 36 
 7
 Generation of C. trachomatis-UV........................................................................ 37 
 RNA and DNA Isolation...................................................................................... 37 
 PCR, Reverse Transcription and RT-PCR........................................................... 37 
 SDS-PAGE and Western Blotting ....................................................................... 38 
 Statistical Analyses .............................................................................................. 38 
Results ....................................................................................................................... 39 
 Nectin-1 Accumulation is Reduced in C. trachomatis-infected HeLa Cells ....... 39 
Nectin-1 Accumulation is Reduced in C. trachomatis-infected HeLa Cells 
from 36 to 60 h.p.i................................................................................................ 40 
Nectin-1 Down-regulation Requires C. trachomatis Protein Synthesis and/or 
Replication ........................................................................................................... 42 
 Viable C. trachomatis EBs are Required for Nectin-1 Down-regulation............ 44 
C. trachomatis Infection of HeLa Cells Does Not Alter Accumulation of 
Nectin-1α, β and γ Transcripts............................................................................. 45 
Discussion.................................................................................................................. 47 
Acknowledgements.................................................................................................... 50 
References.................................................................................................................. 51 
Supplementary Material............................................................................................. 56 
 3. THE HOST ADHERENS JUNCTION MOLECULE NECTIN-1 IS DEGRADED BY 
CHLAMYDIAL PROTEASE-LIKE ACTIVITY FACTOR (CPAF) IN 
CHLAMYDIA TRACHOMATIS-INFECTED GENITAL EPITHELIAL CELLS ....... 59 
Abstract ..................................................................................................................... 60 
Introduction ............................................................................................................... 61 
Materials and Methods .............................................................................................. 63 
 Cell Culture and Chlamydial Infection ............................................................... 63 
 Indirect Immunofluorescence Assay.................................................................... 63 
 Western Blotting .................................................................................................. 64 
 8
 In vivo Proteasome Inhibitor Treatment .............................................................. 65 
 Cell-free Cleavage Assays ................................................................................... 65 
 Statistical Analyses .............................................................................................. 66 
Results ....................................................................................................................... 66 
 Nectin-1 Down-regulation is C. trachomatis Concentration-dependent ............ 66 
The Half-life of Nectin-1 in C. trachomatis-infected Cells is Much Shorter 
than That Observed in Mock-infected Cells ........................................................ 68 
CPAF Expression Correlates with C. trachomatis Infection Time-dependent 
Cleavage of Nectin-1 ........................................................................................... 70 
Nectin-1Down-regulation in C. trachomatis-infected Cells is Inhibited by the 
Proteasome Inhibitor Lactacystin but Not by MG132......................................... 72 
 CPAF is Sufficient for Nectin-1 Degradation in a Cell-free Assay..................... 73 
Discussion ................................................................................................................. 75 
Acknowledgements ................................................................................................... 76 
References ................................................................................................................. 77 
 4. NECTIN-1 IS REQUIRED FOR HERPES SIMPLEX VIRUS (HSV) CO-
INFECTION-INDUCED CHLAMYDIA TRACHOMATIS PERSISTENCE ............... 80 
Summary ................................................................................................................... 81 
Introduction ............................................................................................................... 82 
Methods ..................................................................................................................... 84 
 Cells, Viruses and Chlamydiae ............................................................................ 84 
 Co-infection Experimental Design ...................................................................... 85 
 SDS-PAGE and Western Blotting ....................................................................... 85 
 RNA Isolation, Reverse Transcription and RT-PCR........................................... 86 
 β-galactosidase Assay .......................................................................................... 86 
 Chlamydial Titration by Passage ......................................................................... 87 
 Transmission Electron Microscopy ..................................................................... 87 
 9
 HSV-1 Plaque Assay............................................................................................ 87 
 Statistical Analyses .............................................................................................. 88 
Results ....................................................................................................................... 88 
HeLa and HEC-1B Cells Express Nectin-1 and Nectin-2 but not HVEM .......... 88 
HSV Co-infection Does not Affect the Chlamydial Developmental Cycle in 
the Absence of Nectin-1....................................................................................... 90 
HSV-induced Chlamydial Persistence Requires Nectin-1................................... 93 
HSV Attachment/Entry Using Nectin-1 Alone is Sufficient to Induce 
Chlamydial P 
ersistence.............................................................................................................. 96 
Discussion.................................................................................................................. 98 
Acknowledgements.................................................................................................... 102 
References.................................................................................................................. 103 
Supplementary Material............................................................................................. 107 
 5. CONCLUSIONS ........................................................................................................... 109 
REFERENCES ...................................................................................................................... 124 
VITA ..................................................................................................................................... 145 
 
 
 
 
 
 
 
 
 
 
 
 
 10
LIST OF FIGURES 
 
Figure Page 
 
 1.1. The Chlamydia trachomatis Developmental Cycle.................................................... 14 
 1.2. Transmission Electron Microscopy (TEM) Pictures of Normal and Persistent 
Chlamydiae ................................................................................................................ 16 
 1.3. Replication Cycle of HSV .......................................................................................... 26 
 2.1. Nectin-1 Accumulation is Reduced in C. trachomatis-infected HeLa Cells .............. 40 
 2.2. Nectin-1 Accumulation is Reduced in C. trachomatis-infected HeLa Cells from 36 
to 60 h.p.i ................................................................................................................... 41 
 2.3. C. trachomatis Protein Synthesis and/or Replication is/are Required for Nectin-1 
Downregulation.......................................................................................................... 43 
 2.4. Viable C. trachomatis EBs are Required for Nectin-1 Downregulation .................... 44 
 2.5. C. trachomatis Infection of HeLa Cells does not Alter Accumulation of Nectin-1α, 
β and γ Transcripts ..................................................................................................... 46 
 3.1. Nectin-1 Down-regulation is C. trachomatis Concentration-dependent .................... 67 
 3.2. The Half-life of Nectin-1 in C. trachomatis-infected Cells is Much Shorter than 
that Observed in Mock-infected Cells ....................................................................... 69 
 3.3. CPAF Expression Correlates with the C. trachomatis Infection Time-dependent 
Cleavage of Nctin-1 ................................................................................................... 71 
 3.4. Down-regulation of Nectin-1 in C. trachomatis-infected HeLa Cells is Inhibited by 
the Cytosolic Proteasome Inhibitor Lactacystin but not by MG132.......................... 73 
 3.5. CPAF is Sufficient for Degrading Nectin-1................................................................ 74 
 4.1. HeLa and HEC-1B Cells Express Nectin-1 and Nectin-2 but not HVEM ................. 89 
 4.2. HSV Co-infection does not Affect the Chlamydial Developmental Cycle in the 
Absence of Nectin-1 .................................................................................................. 92 
 11
 4.3. HSV-induced Chlamydial Persistence Requires Nectin-1.......................................... 95 
 4.4. HSV Attachment/entry Using Nectin-1 Alone is Sufficient to Induce Chlamydial 
Persistence.................................................................................................................. 97 
 
Supplementary Figure 
 2.1. Nectin-1 Antibodies CK6 and CK8 Detect the Same Protein .................................... 56 
 2.2. Nectin-1 Accumulation is reduced in C. trachomatis-infected Polarized HeLa Cells 57 
  2.3. Potential Role of Nectin-1 Down-regulation in C. trachomatis Disserminatin 
within the Host Genital Tract..................................................................................... 58 
 4.1. HeLa and HEC-1B Cells Express Nectin-1 and Nectin-2 .......................................... 107 
 4.2. Endogenous Cdc42 Activites upon HSV-1 Infection ................................................. 107 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 12
CHAPTER 1 
 
INTRODUCTION 
 
Chlamydia trachomatis 
 
Members of the genus Chlamydia are the etiologic agents of several important 
human diseases. The species Chlamydia pneumoniae is a widespread respiratory tract 
pathogen that primarily causes community-acquired pneumonia. According to reports 
from the Centers for Disease Control and Prevention (CDC), in the Unites States, 
approximately 50% of young adults and 75% of elderly persons have serological 
evidence of previous C. pneumoniae infection (CDC, 2005). It is estimated that 300,000 
cases of C. pneumoniae pneumonia occur each year. Recently, seroepidemiological 
studies have indicated a possible association between chronic C. pneumoniae infection 
and cardiovascular disease (Kuo et al., 1993; Saikku et al., 1988) as well as late-onset 
Alzheimer’s disease (Balin et al., 1998). In addition, there is evidence linking unresolved 
respiratory C. pneumoniae infection with asthma (Hahn et al., 1991) and chronic 
obstructive pulmonary disease (Blasi et al., 1993). The species Chlamydia psittaci, a 
zoonotic pathogen common in birds, causes psittacosis in humans. Although the illness 
caused by psittacosis is usually mild to moderate in severity, it can be life threatening if 
not properly diagnosed and treated (Kirchner, 1997).  
 
The third major human species of genus Chlamydia is Chlamydia trachomatis, 
which includes two biovars: the Lymphogranuloma Venereum (LGV) biovar and the 
trachoma biovar. The LGV biovar is subdivided into 4 serovars: L1, L2, L2a, and L3.  
They primarily affect lymphatic tissue after invasion through an epithelial surface, 
causing an invasive sexually transmitted disease. LGV infections usually present with 
genital ulcers, papules, or inguinal lymphadenopathy (buboes) (Mabey & Peeling, 2002). 
The trachoma biovar is subdivided into 14 serovars (A-K, Ba, Da, and Ia), based on 
antiserum specificity to the variable region of the major outer membrane protein 
(MOMP). Serovars A, B, Ba, and C are the causative agents of trachoma, the world’s 
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leading cause of infectious blindness (Thylefors et al., 1995). It is estimated that active 
trachoma affects approximately 84 million people, causing an estimated loss of $2.9 
billion in productivity annually (Kumaresan & Mecaskey, 2003), and that about 1.3 
million people are blinded by these bacteria (Wright et al., 2008). Serovars D-K are 
considered the most common sexually transmitted bacterial pathogens worldwide 
(Gerbase et al., 1998), with an estimated 4 million new cases each year in the United 
States. Initial C. trachomatis genital tract infections are often asymptomatic, which 
allows the bacteria to ascend the genital tract undetected, and thus untreated.  Eventually, 
this will lead to severe complications, including epididymitis and prostatitis in men as 
well as salpingitis, endometritis, pelvic inflammatory disease, ectopic pregnancy and 
infertility in women (Darville, 2000a). Infections by C. trachomatis serovars D to K also 
cause neonatal conjunctivitis (Schachter et al., 1986) and pneumonia (Beem & Saxon, 
1977) by vertical transmission through an infected birth canal.  
 
The Chlamydial Developmental Cycle 
 
All chlamydiae are Gram-negative obligate intracellular bacteria and share a 
unique biphasic developmental cycle (Fig. 1.1).  C. trachomatis alternates between two 
morphologically distinct forms. First, the extracellular, infectious but metabolically inert 
form (the elementary body or EB, 0.3µm diameter) attaches to and enters mucosal 
epithelial cells via receptor mediated endocytosis (Wyrick, 2000). EBs are characterized 
by a highly compacted nucleoid due to the condensation by the chlamydial histone-like 
proteins HctA and HctB (Barry et al., 1992; Brickman et al., 1993). EBs have little or no 
peptidoglycan in their cell walls (Ghuysen & Goffin, 1999). Instead, structural rigidity is 
provided by the highly cross-linked outer-membrane complex. Several chlamydial 
ligands (such as MOMP, heat shock protein 70, the outer membrane complex protein 
OmcB, and heparan sulfate-like glycosaminoclycans) and host cell receptors (such as the 
heperan sulfate receptor, the mannose and mannose-6-phosphate receptors, and the 
estrogen receptor) have been proposed to be involved in attachment and entry of 
chlamydiae (Chen & Stephens, 1997; Davis & Wyrick, 1997; Davis et al., 2002; 
Raulston et al., 2002; Stephens et al., 2000; Stephens et al., 2001; Su et al., 1996; Wyrick, 
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2000; Zhang & Stephens, 1992). After entry, EB-containing endosomes avoid fusion with 
host cell lysosomes, intercept sphingomyelin and cholesterol from the exocytic pathway 
and are rapidly trafficked to the perinuclear region of the host cell (Hackstadt et al., 1996; 
Wolf & Hackstadt, 2001). Following these actions, EBs differentiate into larger (1µm 
diameter), metabolically active but non-infectious reticulate bodies (RBs) within an 
enlarged endosomal sac, termed an inclusion. The mature chlamydial inclusion is 
established by insertion of multiple chlamydial proteins and host cell-acquired lipids, 
suggesting chlamydiae actively modify the inclusion and manipulate the host cell to 
provide a protected intracellular niche (Hackstadt et al., 1996; Hackstadt et al., 1997; 
Wylie et al., 1997). Using ATP and metabolites from the host cell, RBs grow and divide 
by binary fission. After 8-12 rounds of replication, the RBs mature into infectious EBs, 
which are released from the host cell (Wyrick, 2000).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1 The Chlamydia trachomatis developmental cycle. (Courtesy Jennifer Vanover) 
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Chlamydial Persistence 
 
The normal chlamydial developmental cycle can be interrupted when developing 
chlamydiae are exposed to unfavorable environmental factors  (Beatty et al., 1994a; 
Darville, 2000a; Gerard et al., 2001; Raulston, 1997). In this situation, the chlamydiae 
deviate from the normal developmental cycle into a state termed persistence (Hogan et al., 
2004) and can remain in this state for weeks or months (Galasso & Manire, 1961). 
Although chlamydial persistence in vivo has been difficult to demonstrate, recent studies 
strongly suggest that chlamydiae do become persistent in humans (Dean et al., 2000; 
Fortenberry et al., 1999; Gerard et al., 2001; Gerard et al., 2002; Patton et al., 1994). 
Development of persistence is thought to be a mechanism used by the chlamydiae to 
ensure survival under stressful conditions of growth and development (Harper et al., 2000; 
Mpiga & Ravaoarinoro, 2006).  
 
Persistent chlamydiae have been traditionally described as a viable but culture-
negative form of chlamydiae (Beatty et al., 1994b) (Fig. 1.2). During the persistent state, 
chlamydiae continue to synthesize unprocessed 16S rRNA and replicate chromosomes 
(Gerard et al., 1998; Gerard et al., 2001). The RBs continue to enlarge but neither 
undergo binary fission nor differentiate back into EBs, thus resulting in enlarged RBs and 
decreased EB infectivity (Beatty et al., 1993; Beatty et al., 1994a). At the ultrastructural 
level, persistent chlamydiae appear as swollen, misshapen, diffuse RBs.  Inclusions 
containing persistent chlamydiae often contain large numbers of membrane blebs. In 
addition, it is reported that, during persistent state, accumulation of MOMP is decreased 
while the accumulation of the immunodestructive antigen HSP60 is stable or increased 
(Beatty et al., 1993; Beatty et al., 1994b). Finally, because they are still viable, persistent 
chlamydiae have ability to re-enter and complete the normal developmental cycle once 
the persistence “inducer” is removed.  
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Figure 1.2 Transmission electron microscopy (TEM) pictures of normal and persistent 
chlamydiae.  
 
 
 
Since chlamydial persistence represents a long-term relationship between the 
chlamydiae and their host cells, there has been a great amount of interest within the field 
to further define this phenomenon. So far, several different factors have been discovered 
to induce chlamydial persistence in vitro, including interferon-γ (IFN-γ), tumor necrosis 
factor-α (TNF-α), or penicillin G exposure as well as amino acid, iron, or glucose 
deprivation. Persistence has also been reported to develop following phage infection of 
chlamydiae (Hsia et al., 2000) or chlamydial infection of monocytes (Koehler et al., 
1997). Spontaneous development of chlamydial persistence has also been found to occur 
in continuous cultures without presence of any stresses (Shatkin et al., 1985).  
 
Propagation of chlamydiae in host cells deprived of amino acids, glucose, or iron 
has been shown to induce persistence. Under iron restriction, the inclusions of C. 
trachomatis serovar E are small and surrounded by electron-dense material (Raulston, 
1997). The RBs within these inclusions become abnormal with loose and wavy outer 
Normal chlamydiae Persistent chlamydiae
7000 X 7000 X
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membranes (Raulston, 1997). Minor reductions in amino acids or glucose concentration 
in culture media also induce persistence (Coles et al., 1993; Harper et al., 2000). In all 
cases where nutrient restriction has been used to induce persistence, the chlamydiae re-
enter the normal developmental cycle following supplementation with the appropriate 
nutrients (Coles et al., 1993; Harper et al., 2000; Raulston, 1997).  
 
Of the cytokine-induced persistence models, IFN-γ-induced persistence has been 
best characterized. For example, infection of HeLa cells with C. trachomatis serovar A 
followed by exposure to 0.2 µg/ml IFN-γ produces small chlamydial inclusions 
containing enlarged and abnormal RBs (Beatty et al., 1993). The mechanism behind this 
phenomenon is that IFN-γ exposure increases host cell indoleamine 2,3-dioxygenase 
(IDO) expression, leading to the conversion of tryptophan to N-formylkynurenine. The 
resultant tryptophan deficiency drives the developing chlamydiae into the persistent state. 
Removal of IFN-γ from the culture media or addition of tryptophan to the culture media 
allows the persistent chlamydiae to recover and resume normal growth (Beatty et al., 
1993; Byrne et al., 1986). In murine cells, IFN-γ exposure induces chlamydial persistence 
via a different mechanism. IFN-γ activates the p47 GPTase, Iigp1, which inhibits 
chlamydial development by restricting vesicular trafficking to the developing inclusions 
(Nelson et al., 2005).   
 
Finally, many researchers have also observed that exposure of chlamydia-infected 
cells to antibiotics, such as penicillin, ofloxacin, or ciprofloxacin, induces development of 
greatly enlarged and aberrant RBs (Dreses-Werringloer et al., 2000; Johnson & Hobson, 
1977; Segreti et al., 1992). The RBs resume normal growth after removal of antibiotics. 
Generally, agents that target chlamydial RNA or protein synthesis inhibit chlamydial 
differentiation from EB to RB or from RB to EB, while those that target DNA or 
peptidoglycan synthesis inhibit only RB to EB differentiation (Moulder, 1991). These 
observations indicate that inappropriate antimicrobial therapy may be a significant cause 
of persistent chlamydial infection in vivo.  
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Chlamydia Protease-like Activity Factor (CPAF) 
 
The unique, biphasic chlamydial developmental cycle involves a complex 
interaction between the pathogen and its obligate host. To ensure their successful 
intracellular replication and long-term survival within infected host cells, chlamydiae 
have evolved various strategies to evade host defense systems and to modulate host cell 
functions. For example, during chlamydial infection, chlamydiae prevent productively 
and persistently infected host cells from undergoing apoptosis, which may allow them to 
maintain long-term survival within infected cells (Dean & Powers, 2001; Dong et al., 
2005a; Fan et al., 1998; Fischer et al., 2004; Geng et al., 2000; Pirbhai et al., 2006; 
Rajalingam et al., 2001). Chlamydiae alter host cell-cell contacts to facilitate chlamydial 
growth (Prozialeck et al., 2002). Chlamydiae can also modify host cell cytoskeletal 
arrangement and signal transduction to benefit chlamydial intravacuolar replication 
(Clausen et al., 1997; Majeed & Kihlstrom, 1991; Majeed et al., 1993; Schramm & 
Wyrick, 1995; Xia et al., 2003).  
 
Another strategy that chlamydiae use to survive in their intracellular habitat is the 
secretion of chlamydia protease-like activity factor (CPAF). CPAF is synthesized within 
the chlamydial inclusion and subsequently secreted into the host cell cytoplasm (Fan et 
al., 2002; Zhong et al., 2001). CPAF has been shown to be produced by the two human 
pathogens C. trachomatis and C. pneumoniae as well as by the three non-human 
pathogens, C. muridarum, C. psittaci and C. caviae (Dong et al., 2005b; Fan et al., 2002; 
Zhong et al., 2001). Further studies demonstrated that there is little or no difference in 
CPAF expression between persistent and productive chlamydial infections, suggesting 
that CPAF production may be important in both types of infection (Heuer et al., 2003; 
Shaw et al., 2002). CPAF is encoded by a single open reading frame (ORF) in the 
chlamydial genome, but the main purified product consists of two fragments. CPAF is 
initially produced as an inactive proenzyme of 70 kDa and rapidly processed into two 
fragments, a 35 kDa C-terminal portion (designated CPAFc) and a 29 kDa N-terminal 
portion (designated CPAFn), which must form intramolecular dimers to acquire 
proteolytic activity (Dong et al., 2004a; Dong et al., 2004b). Studies by Dong et al 
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further confirmed that cleavage of CPAF is both necessary and sufficient for CPAF 
activity (Dong et al., 2004a). The proteolytic activity of CPAF is inhibited by the 
cytosolic proteasome inhibitor lactacystin but not by other proteasome inhibitors such as 
MG132 and MG115, or by broad spectrum protease inhibitors, such as PMSF and 
pepstatin A (Zhong et al., 2000; Zhong et al., 2001).  
 
A number of studies suggest that CPAF plays important roles in promoting 
chlamydial replication and protecting infected cells from host immune detection. For 
example, CPAF has been shown to cleave RFX5 and USF-1, two eukaryotic transcription 
factors required for both major histocompatibility complex (MHC) class I and II antigen 
expression (Zhong et al., 1999; Zhong et al., 2000). This process may help infected cells 
escape immune detection so that the chlamydiae have sufficient time to complete their 
replication in infected hosts. Similarly, CPAF has been found to be responsible for 
degrading keratin-8 (Dong et al., 2004c), pro-apoptotic BH-3 only proteins (Pirbhai et al., 
2006), and CD1d glycoprotein (Kawana et al., 2007). Keratin-8 is a key subunit of 
intermediate filaments in epithelial cells. Cleavage of keratin-8 would increase the 
solubility of the host cell cytoskeleton, thus facilitating the expansion of chlamydia-laden 
inclusion, which is essential for chlamydial intracellular replication. Pro-apoptotic BH-3 
only proteins are required for apoptosis induction in response to cytotoxic stimuli or 
exogenous stress, and they function by neutralizing their pro-survival counterparts or 
activating pro-apoptotic Bcl-2 family members Bax and Bak (Bouillet & Strasser, 2002). 
Down-regulation of BH-3 only proteins contributes to chlamydial anti-apoptotic activity 
which may help chlamydiae evade CTL-mediated host cell apoptosis induction and, thus, 
benefit chlamyidal long-term survival within infected host cells (Pirbhai et al., 2006).  
CD1d glycoprotein is an MHC-like protein that presents lipid antigens to natural killer T 
cells. Degradation of CD1d protein may prevent recognition or elimination of chlamydiae 
from the host innate immune system (Kawana et al., 2007). Taken together, CPAF, the 
first example of a cytoplasmically localized chlamyidal protease, seems to execute its 
functions by degrading host cell proteins to either facilitate chlamydial intravacuolar 
replication or help chlamydiae evade host immune surveillance.  
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Nectins 
 
In epithelial cells, intercellular adhesions are intimately involved in maintaining 
cell structure, transmitting information, regulating cellular migration, and imparting 
strength and rigidity to tissues (Farquhar & Palade, 1963; Gumbiner, 1996; Takeichi, 
1995). Intercellular adhesions are mainly maintained by cell-cell adherens junctions (AJs) 
and tight junctions (TJs) (Farquhar & Palade, 1963). Importantly, the organization and 
functions of TJs are dependent on the formation and maintenance of AJs (Tsukita & 
Furuse, 1999). TJs are formed at the apical side of AJs and regulate selective diffusion of 
solutes and water along the paracellular pathway. Thus, TJs act as a fence between the 
apical and basolateral plasma membrane domains in epithelial cells (Tsukita et al., 1999; 
Tsukita et al., 2001). At TJs, three cell adhesion molecules (CAMs) {claudin, occludin, 
and junctional adhesion molecule (JAM)} have been identified, and they are linked to the 
actin cytoskeleton through peripheral membrane proteins such as ZO-1, -2 and -3 
(Tsukita et al., 2001).  AJs are located immediately at the basal side of TJs and connect 
the lateral surfaces of adjacent epithelia cells. AJs form complexes with actin and myosin 
filaments to internally brace cells and thereby control their shape. AJs play important 
roles not only in the formation and maintenance of TJs, but also in concentrating 
biologically active molecules such as cell surface receptors, signaling molecules, and 
oncoproteins (Gumbiner, 2000; Nagafuchi, 2001; Perez-Moreno et al., 2003; Tsukita et 
al., 1992; Van Aelst & Symons, 2002). E-cadherin, an important component of AJs, is a 
Ca2+-dependent cell-cell adhesion molecule found in epithelial cells (Takeichi, 1991). E-
cadherin is a member of the cadherin superfamily, which consists of more than 80 
members. Most cadherins are single-membrane-spanning molecules and are associated 
with the actin cytoskeleton through peripheral membrane proteins, including α- and β-
catenins, vinculin, and α-actinin (Gumbiner, 2000; Nagafuchi, 2001; Takeichi, 1995). It 
was previously believed that AJs were formed by cadherins, but recent evidence indicates 
that AJs are formed by both cadherins and nectins (Irie et al., 2004; Nakanishi & Takai, 
2004; Ogita & Takai, 2006a; Sakisaka & Takai, 2004; Shimizu & Takai, 2003; Takai et 
al., 2003; Takai & Nakanishi, 2003; Takeichi, 1991).  
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Nectins are Ca2+-independent, immunoglobulin (Ig)-like cell-cell adhesion 
molecules with three extracellular Ig-like loops, a single transmembrane region (except 
for nectin-1γ) and a cytoplasmic tail. The nectin family currently contains at least 4 
members (nectins-1~4) (Sakisaka & Takai, 2004; Takai & Nakanishi, 2003). Nectin-1, 
nectin-2 and nectin-3 are widely distributed in a variety of tissues and cell types, such as 
epithelial cells, neurons, and fibroblasts (Takai & Nakanishi, 2003). Nectin-2 and nectin-
3 are also found in blood cells and spermatids, where cadherins are not expressed 
(Bouchard et al., 2000; Lopez et al., 1998; Ozaki-Kuroda et al., 2002). Human nectin-4 
appears to be primarily distributed in placenta (Reymond et al., 2001). Each nectin first 
forms cis-dimers homophilically and then the cis-dimers homophilically or 
heterophilically interact in trans with each other to form trans-dimers. The 
heterophilically formed trans-interactions are stronger than the homophilically formed 
trans-interactions (Sakisaka & Takai, 2004). In contrast, cadherins only can form 
homophilic trans-dimers (Takeichi, 1995). In addition to interacting with each other, 
nectins also interact in trans with other Ig-like molecules such as nectin-like molecules 
(Necls), CD226/DNAM-1, and CD96/Tactile (Bottino et al., 2003; Ikeda et al., 2003; 
Kakunaga et al., 2005; Seth et al., 2007; Shingai et al., 2003). The cytoplasmic tail of 
each nectin member binds to afadin, an actin filament (F-actin)-binding protein, which 
connects nectin to the actin cytoskeleton (Takai & Nakanishi, 2003). Afadin has multiple 
domains and acts as an adaptor protein by binding many scaffolding proteins and F-actin-
binding proteins, associating nectins with other cell-cell adhesion and intracellular 
signaling pathways (Takai et al., 2008). This novel nectin-afadin adhesion system is 
required not only for the formation of AJs but also for the subsequent formation of TJs, 
as well as for the formation of functional cell-cell junctions, acting cooperatively with or 
independently of cadherins (Takai & Nakanishi, 2003). Additionally, this nectin-afadin 
adhesion system has been shown to be novel mediator of many other cellular events 
including movement, proliferation, differentiation, polarization, and the entry of viruses 
by interacting with other CAMs and cell surface receptors. For example, trans-
interactions of nectins induce the activation of c-Src. The activated c-Src stimulates the 
small G proteins Cdc42 and Rac, which are eventually involved in cell-cell adhesion 
through reorganization of the actin cytoskeleton, gene expression by activation of the 
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JNK pathway, and cell polarization by cell polarity proteins (Honda et al., 2003; 
Kawakatsu et al., 2002). Furthermore, this adhesion system regulates the formation of 
synapses in neurons and the organization of heterotypic junctions between Sertoli cells 
and spermatids in the testis (Bouchard et al., 2000; Mizoguchi et al., 2002; Ozaki-Kuroda 
et al., 2002).  
 
The functions of nectin-1 and nectin-2 in mediating the entry of viruses into host 
cells have been extensively studied. The cDNAs of nectin-1 and nectin-2 were originally 
described as encoding poliovirus-receptor-related proteins, and, therefore were named 
PRR-1 and PRR-2 (Eberle et al., 1995; Lopez et al., 1995).  However, neither PRR-1 nor 
PRR-2 has been shown to serve as a poliovirus receptor. Because they were later 
demonstrated to serve as receptors for α-herpes viruses, they were renamed HveC and 
HveB, respectively (Geraghty et al., 1998; Warner et al., 1998). Finally, they were 
renamed nectin-1 and nectin-2, respectively, due to their roles in cell-cell adhesion. 
Nectin-1 and nectin-2 have different affinity specificities for wild-type 
alphaherpesviruses. Nectin-1 mediates entry of all α-herpes viruses tested so far, 
including herpes simplex virus type I (HSV-1) and type 2 (HSV-2), as well as 
pseudorabies virus (Campadelli-Fiume et al., 2000; Spear et al., 2000). In contrast, 
nectin-2 primarily mediates the entry of HSV-2 into host mucosal epithelial cells 
(Campadelli-Fiume et al., 2000; Spear et al., 2000). It remains unknown whether nectin-3 
and nectin-4 serve as receptors for viruses.  
 
Herpes Simplex Virus (HSV) 
 
HSV-1 and HSV-2 are members of the viral family Herpesviridae and cause a 
range of infections from mild uncomplicated mucocutaneous infection to life threatening 
disease such as meningitis. Although both HSV-1 and HSV-2 can infect either oral or 
genital sites, HSV-1 is more often associated with oral infections such as cold sores or 
fever blisters, while HSV-2 is considered the primary etiological agent of genital herpes. 
HSV can infect many cell types, but the two most important cellular targets are 
mucosal/skin epithelial cells and neurons. After primary infection of epithelial cells, the 
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virus establishes latent infection within sensory and autonomic neurons whose axons 
extend to the locale of the lesions. Latent infection can be periodically reactivated in 
response to many stimuli such as colds and influenza, emotional and physical stress, 
immune suppression, exposure to bright sunlight, gastric upset, fatigue, or injury. 
Reactivated virus transports, via the nerve’s axon, back to the site of original infection to 
cause recurrent lesions. Most people suffer an average of 5 reactivations per year, during 
which lesions and virions are present (Corey et al., 1983). Evidence also suggests that 
HSV-2 is commonly shed in the absence of detectable symptoms (Mertz et al., 1992).  
 
The HSV virion has a large double-stranded DNA genome about 150 kbp. The 
genome is packed within a capsid, an icosahedral protein cage, containing 162 capsomers 
or morphological elements (Spear, 2004). The capsid is in turn coated with a protein layer 
(the tegument) and, subsequently, an envelope composed of lipids and more than a dozen 
viral proteins and glycoproteins. Several envelope glycoproteins are essential for viral 
entry (Spear, 2004). HSV-1 and HSV-2 each contain at least 74 genes within their 
genomes, encoding proteins involved in forming the viral capsid, tegument and envelope, 
as well as controlling the replication and infectivity of the virus (Dolan et al., 1998).  
 
Entry of HSV (Fig. 1.3A) into host cells is initiated when the virion binds to the 
cell surface receptor heparan sulfate using the viral envelope proteins gC and/or gB (to a 
lesser extent). Although this binding of gC or gB with heparan sulfate significantly 
increases the efficiency of HSV infection, it is not absolutely essential (Spear, 2004).  
After initial binding, the viral gD envelope glycoprotein interacts with one of 4 cellular 
co-receptors including HVEM (herpes virus entry mediator), nectin-1, nectin-2, or 3-O 
sulfated heparan sulfate (3-O-S-HS) (Spear, 2004). HVEM is a member of the tumor 
necrosis factor (TNF) receptor family which is present on B and T lymphoctyes, other 
leucocytes, fibroblasts, and epithelial cells, but not on neurons (Hsu et al., 1997; Kwon et 
al., 1997; Marsters et al., 1997; Montgomery et al., 1996).  HVEM can be used as a co-
receptor by both HSV-1 and HSV-2 with equally high efficiency (Spear, 2004). Nectin-1 
and nectin-2, as described in the nectins section, are two cell adhesion molecules 
belonging to the immunoglobulin superfamily which are expressed on fibroblasts, 
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neurons, and epithelial cells. Nectin-1 mediates entry of both HSV-1 and HSV-2, while 
nectin-2 primarily mediates entry of HSV-2 (Spear, 2004). 3-O-S-HS is wildly 
distributed on human cells and primarily mediates HSV-1 entry (Spear, 2004). Binding of 
gD to any one of the these co-receptors facilitates the fusion of viral envelope with the 
host cell plasma membrane. Viral envelope-membrane fusion also requires assistance 
from viral gB and gH/gL proteins (Spear et al., 2000; Spear, 2004). HSV was previously 
believed to enter cells only via envelope-membrane fusion, but recently it has been 
reported that HSV entry can also occur through direct penetration of the cell plasma 
membrane or by endocytic pathways, depending on the host cell line used.  
 
After fusion occurs, the virus releases the capsid-tegument structure into the 
cytoplasm (Fig. 1.3B). Subsequently, the capsid is transported to the host nucleus where 
the viral DNA genome circularizes and is transcribed. Immediate early genes (or α-genes) 
are first transcribed which are involved in transcriptional regulation and are not found in 
the mature virion. They also promote transcription of early genes (or β-genes). Early 
proteins include DNA polymerase and enzymes, which are mainly involved in DNA 
replication. Late genes (or γ-genes), transcribed after DNA synthesis, are translated in the 
cytoplasm and then transported back to the nucleus. Viral envelope glycoproteins are 
synthesized in the rough endoplasmic reticulum where they obtain high mannose sugar 
chains. They are then processed by the host secretory pathway and localized to the 
nuclear and cytoplasmic membranes, where they are surface exposed. New virions are 
assembled in the nucleus, bud through the nuclear membrane via areas in which the viral 
envelope glycoproteins are enriched, and egress the host cell by vesicular transport 
(Roizman, 2001b).  
 
Numerous studies have demonstrated that HSV infection can modulate host cell 
signal transduction pathways. Yokota et al has reported that during the early stage (2 to 3 
hour post infection) of HSV-1 infection in human amnion FL cells, the IFN signal 
pathway is suppressed by inhibiting IFN-induced phosphorylation of STATs and Janus 
kinases (Yokota et al., 2001). In HSV-infected T cells, T cell receptor (TCR) signal 
transduction is suppressed by inhibition of the activation of LAT (linker for activation of 
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T cells) and the steps distal to LAT in the TCR signal cascade, including inhibition of 
calcium flux and multiple MAPK (Sloan et al., 2006). In human monocyte cell lines, 
interaction of gD with HVEM is involved in NF-κB-dependent protection against 
apoptosis (Sciortino et al., 2008; Teresa Sciortino et al., 2007). HSV infection also 
induces the expression of host cellular suppressor of cytokine signaling-3 (SOCS3), a 
negative regulator of the JAK/STAT pathway (Yokota et al., 2005), conferring efficient 
viral replication. Additionally, Hoppe et al have demonstrated that the small Rho-like 
GTPases Rac1 and Cdc42 are activated at 15 to 30 minutes after HSV-1 infection of 
epithelial MDCK canine kidney cells (Hoppe et al., 2006). Inhibition of Cdc42 activity 
using a dominant-negative inhibitor decreased both Cdc42 activation and subsequent 
viral replication. Since Rac1 and Cdc42 are members of the nectin-1 trans-interaction 
induced signaling pathway, it is speculated that HSV-1/nectin-1 interaction is responsible 
for activation of Rac1 and Cdc42 (Hoppe et al., 2006).  
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Figure 1.3 Replication cycle of HSV. A. Attachment and entry of HSV virions into the 
host cell. B. Replication and release of HSV from the host cell.  
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HSV and C. trachomatis Co-infection 
 
Despite substantial improvement in the prevention of sexually transmitted 
diseases (STDs), they still represent a substantial fraction of the disease burden. 
According to reports from the CDC, STDs are among the most common infections in the 
United States. Approximately 19 million new cases of STDs occur each year in the 
United States, almost half of them among people ages 15 to 24 (CDC, 2006; Weinstock 
et al., 2004). In addition to the health consequences of STDs, these diseases also cause a 
severe economic burden. The direct medical costs of treating these diseases were 
estimated at up to 14.7 billion dollars in the United States in 2006 (CDC, 2006). 
Moreover, epidemiological studies have demonstrated that infection with one STD 
increases the chance for individuals to acquire others (Cameron et al., 1989; Laga et al., 
1993; Plummer et al., 1991). For instance, HSV-2 infection increases the risk for 
acquiring Human Immunodeficiency Virus (HIV) infection by 3-fold (Freeman et al., 
2007).  
 
In the United States, two of the most common STD agents are C. trachomatis 
(serovars D-K), causing 4 million new infectious diseases annually and HSV (primarily 
HSV-2), causing 200,000-500,000 new infectious cases annually (Johnson et al., 1989).  
A number of studies have shown that C. trachomatis and HSV-2 co-infections occur in 
vivo. Both pathogens have been simultaneously isolated from the genital tract of women 
afflicted with endometritis and salpingitis (Paavonen et al., 1985) or cystitis (Tait et al., 
1985). Serological studies indicate that HSV-2 positive individuals are likely to be C. 
trachomatis-positive as well (Paroli et al., 1990; Silins et al., 2002; Vetter et al., 1990). 
In addition, seropositivity rates of > 50% for both HSV-2 and C. trachomatis have been 
reported, implying that some participants had been exposed to both pathogens (Duncan et 
al., 1992; Wagner et al., 1994). Although IgG seropositivity can not be used to establish 
concurrent infection, it is likely that both organisms were present simultaneously in the 
genital tracts of some individuals, since C. trachomatis often causes long-term infections 
and HSV-2 reactivates on average 5 times per year.  
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Several groups have also established HSV/C. trachomatis co-infection in cell 
culture. Chiarini et al demonstrated that the number of cells positive for chlamydiae by 
immunofluorescence was reduced when HeLa cells were co-infected with HSV-2/C. 
trachomatis serovar D (Chiarini et al., 1996). Pontefract et al observed that Vero cells co-
infected with C. trachomatis serovar L2 and HSV-2 contained swollen inclusions with 
few RBs or EBs (Pontefract et al., 1989). HSV-2 pre-infection of HT-1376 human 
bladder cells reduced production of infectious C. trachomatis EBs by about 15-fold 
(Superti et al., 2001). These observations indicated that HSV-2 co-infection might alter 
the chlamydial developmental cycle in a way similar to that observed during persistent 
infections.  
 
Summary of Previous Co-infection Studies from Our Laboratory 
 
Although previous studies on HSV-2/C. trachomatis co-infection suggested that 
HSV-2 co-infection alters chlamydial development, these studies did not examine the co-
infection process in detail. Recently, we developed a tissue culture model of HSV-2/C. 
trachomatis serovar E co-infection. Data from this model indicate that HSV-2 super-
infection of C. trachomatis-infected genital epithelial cells induces chlamydial 
persistence, as evidenced by significantly decreased infectious chlamydial EB production, 
abnormal RB morphology, increased membrane blebs and vesicles within inclusions, as 
well as continued accumulation of chlamydial genomic DNA and unprocessed RNA, but 
no infectivity (Deka et al., 2006).  
 
Furthermore, co-infection of HeLa or HEC1B cells with C. trachomatis serovar E 
and either HSV-2 or HSV-1 reduces chlamydial EB titer, alters inclusion ultrastructure 
but does not reduce chlamydial DNA copy number, indicating that induction of 
chlamydial persistence by HSV is neither host cell type nor virus strain specific (Deka et 
al., 2007). UV-inactivated HSV (HSV-2uv) attaches to and enters host cells but does not 
replicate (Moxley et al., 2002).  Cyclohexamide, a well known eukaryotic protein 
synthesis inhibitor, inhibits de novo synthesis of host cell proteins (Vasquez, 1979) and 
all kinetic classes of HSV proteins as well as preventing HSV productive replication 
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(Fenwick & Walker, 1978; Swanstrom et al., 1975) but does not affect C. trachomatis 
development (Ripa & Mardh, 1977). Co-infection of HeLa cells with HSV-2uv or with 
replication-competent HSV-2 in the presence of cyclohexamide continues to drive C. 
trachomatis into a persistent state, suggesting productive HSV replication is not required 
for induction of chlamydial persistence, and HSV attachment or entry is sufficient for this 
effect (Deka et al., 2007).  
 
Global deprivation of amino acids, iron, or glucose can cause developing 
chlamydiae to enter persistence (Harper et al., 2000; Hogan et al., 2004; Raulston, 1997). 
However, supplementation of HSV-2/C. trachomatis co-infected cells with excess amino 
acids, iron-saturated transferrin, glucose, or a combination of amino acids and glucose 
does not rescue EB infectivity, suggesting that viral co-infection-induced chlamydial 
persistence is not due to amino acid, iron, or glucose deprivation (Vanover et al., 2008). 
Luminex assays indicate that IFN-γ, IFN-α and TNF-α, three well-studied inducers of 
chlamydial persistence, are not released from co-infected cells. Semiquantitative RT-PCR 
experiments demonstrate that IFN-β, IFN-γ, IDO, lymphotoxin-α, and inducible nitric 
oxide synthase (iNOS) are not expressed during co-infection. These data indicate that 
viral-induced persistence is not stimulated by any cytokine currently known to induce 
host anti-chlamydial responses (Vanover et al., 2008). Also, inclusions within co-infected 
cells continue to enlarge and incorporate C6-NBD-ceramide, indicating that HSV-2 co-
infection does not inhibit vesicular transport to the developing inclusion (Vanover et al., 
2008). Therefore, taken together, these data demonstrate that HSV co-infection-induced 
chlamydial persistence is not mediated by any currently identified persistence inducer or 
anti-chlamydial pathway (Vanover et al., 2008).  
 
Studies show that persistent chlamydiae re-enter the normal developmental cycle 
and re-gain infectivity following removal of persistence inducers or replacement of 
deficient/depleted nutrients (Harper et al., 2000; Matsumoto & Manire, 1970; Raulston, 
1997). Our unpublished data indicate that chlamydiae can recover infectivity within 44hr 
during long-term co-infection with UV-inactivated HSV-2, demonstrating that, like other 
persistence inducers, HSV-induced chlamydial persistence is reversible (Vanover, 2009b). 
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Moreover, contact between paraformaldehyde-fixed, HSV-2-infected cells and viable C. 
trachomatis-infected cells induces chlamydial persistence, indicating that HSV entry is 
not required for chlamydial persistence induction and suggesting that interaction between 
HSV surface glycoproteins and a host cell receptor is sufficient for triggering chlamydial 
persistence (Vanover, 2009b). More importantly, subsequent studies in our laboratory 
determined that HSV glycoprotein D interaction with host cell surface renders sufficient 
stimulus to induce chlamydial persistence, probably via a novel host anti-chlamydial 
pathway (Vanover, 2009b).  
 
Questions to be Answered in the Studies 
 
Upon infection, chlamydiae modulate host cell functions in a variety of ways in 
order to ensure their replication, dissemination, and long-term survival within infected 
hosts. It has been reported that C. trachomatis infection disturbs cell-cell contacts 
between polarized epithelial cells in culture (Wyrick et al., 1989). Notably, release of C. 
trachomatis-infected epithelial cells has been observed in vivo as well (Doughri et al., 
1972; Soloff et al., 1985). In both studies by Doughri et al and Soloff et al, the authors 
hypothesized that polymorphonuclear neutrophils (PMNs) responding to chlamydial 
infection promote detachment of chlamydia-infected cells from the mucosal surface, 
resulting in the release of intact, infected cells into the cervical lumen (Doughri et al., 
1972; Soloff et al., 1985). However, in the absence of PMNs, Prozialeck et al have 
observed that chlamydial infection also loosens cell-cell contacts by promoting 
breakdown of the N-cadherin/β-catenin complex (Prozialeck et al., 2002), suggesting that 
the developing chlamydiae may contribute directly to the release of observed in vivo of 
infected cells from the infected mucosa. Recently, it has been elucidated that the nectin-
based adhesion system is required not only for the formation of AJs but also for the 
subsequent formation of TJs as well as for the formation and maintenance of functional 
cell-cell junctions, acting cooperatively with or independently of cadherins (Takai & 
Nakanishi, 2003). To find out whether C. trachomatis infection alters nectin-1 in genital 
epithelial cells, we have systematically examined the accumulation and expression level 
of nectin-1 using Western blotting, immunofluorescence assay and RT-PCR analyses. 
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Our data indicated that nectin-1 accumulation is significantly decreased at the post-
transcriptional level in C. trachomatis-infected genital epithelial cells and suggested that 
C. trachomatis may disrupt AJs, at least in part, by diminishing nectin-1 expression.  This 
work has been published in Microbiology (2008, 154:1290-1299) (Sun et al., 2008) and is 
presented here as Chapter 2.  
 
CPAF, a chlamydia-secreted protease, has been reported to degrade a number of 
host cell proteins during chlamydial infection, including transcription factors RFX5 and 
USF-1, keratin-8, pro-apoptotic BH-3 only proteins, and CD1d glycoprotein (Dong et al., 
2004c; Kawana et al., 2007; Pirbhai et al., 2006; Zhong et al., 1999; Zhong et al., 2000). 
Given the broad range of cellular proteins that CPAF targets, we hypothesized that CPAF 
may degrade nectin-1 in C. trachomatis-infected genital epithelial cells. To elucidate the 
molecular mechanism by which chlamydiae down-regulate nectin-1, we determined 
whether or not CPAF degrades nectin-1. This work has been published in Microbes and 
Infection (2009, 11:12-19) (Sun, 2009) and is presented here as Chapter 3.  
 
HSV gD is the main determinant of cell recognition for viral entry. Fusion of the 
HSV envelope and host cell membrane is mediated by the binding of HSV gD to one of 
its co-receptors (HVEM, nectin-1, nectin-2 and 3-O-S-HS). Unpublished data from our 
laboratory indicate that HSV glycoprotein D (gD) interaction with the host cell surface is 
sufficient to induce chlamydial persistence (Vanover, 2009b). Subsequently, we 
determined that virus interaction with one of the known co-receptors is sufficient to alter 
the chlamydial developmental cycle. This work has been summarized in a manuscript 
“Nectin-1 is required for Herpes simplex virus (HSV) co-infection-induced Chlamydia 
trachomatis persistence” and is presented here as Chapter 4.  
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CHAPTER 2 
 
THE HOST ADHERENS JUNCTION MOLECULE NECTIN-1 IS DOWN-
REGULATED IN CHLAMYDIA TRACHOMATIS-INFECTED GENITAL EPITHELIAL 
CELLS 
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Summary 
 
Nectin-1, a member of the immunoglobulin superfamily, is a Ca2+-independent 
cell adhesion protein implicated in the organization of E-cadherin-based adherens 
junctions (AJs) and claudin-based tight junctions (TJs) in epithelial cells. Nectin-1 also 
regulates cell–cell adhesion and cell polarization in a Cdc42- and Rac-dependent manner. 
Western blot analyses demonstrated that accumulation of host nectin-1 is decreased by 85 
% at 48 hours post-infection (h.p.i.) in Chlamydia trachomatis serovar E-infected HeLa 
cells. Time-course experiments demonstrated that this decrease was sustained to 60 h.p.i. 
Nectin-1 downregulation in C. trachomatis-infected cells was prevented by both 
chloramphenicol exposure and prior inactivation of the chlamydiae with UV light, 
demonstrating that active C. trachomatis replication was required. Penicillin G-exposure 
studies demonstrated that nectin-1 accumulation was also altered during persistent 
infection. Finally, RT-PCR analyses indicated that chlamydial infection did not alter 
accumulation of any nectin-1 transcripts, demonstrating that nectin-1 accumulation is 
reduced at a post-transcriptional level. Intesrestingly, N-cadherin-dependent cell–cell 
junctions can be disrupted by C. trachomatis infection, as reported by Prozialeck et al. 
(2002) . Because interaction of nectin molecules on adjacent cells is essential for AJ 
formation, these data suggest that C. trachomatis may disrupt AJs, at least in part, by 
diminishing nectin-1 accumulation. Notably, release of chlamydiae-infected epithelial 
cells has been observed both in vitro from polarized monolayers and in vivo from tissues, 
suggesting that chlamydia-modulated downregulation of adhesion molecules and the 
subsequent disruption of host cell adherence may be involved in chlamydial 
dissemination or pathogenesis. 
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Introduction 
 
The obligate intracellular bacterium Chlamydia trachomatis is a significant Gram-
negative human pathogen, with 4 million new cases per year in the USA. Long-term C. 
trachomatis genital tract infections are often asymptomatic and associated with severe 
ascending complications, including epididymitis, prostatitis, ectopic pregnancy, 
salpingitis, and infertility (Darville, 2000a). The chlamydial developmental cycle begins 
when the elementary body (EB) binds to and enters mucosal epithelial cells. Once 
internalized, the EB remains within an inclusion and differentiates into a reticulate body 
(RB). Using host cell nutrients, the RB grows, divides by binary fission and eventually 
produces more EBs, which are released by host cell lysis (Wyrick, 2000). When 
developing chlamydiae are confronted with nutrient deficiency or penicillin exposure, 
they deviate from the normal developmental cycle and enter into a state called persistence, 
which is characterized by formation of aberrantly enlarged, viable but non-infectious 
chlamydial RB (Hogan et al., 2004). Notably, the chlamydiae can re-enter and complete 
the normal developmental cycle once the persistence “inducer” is removed.  
 
Upon infection, chlamydiae alter host cellular functions in a variety of ways. 
Chlamydial infection prevents host cell apoptosis, induces reorganization of the actin 
cytoskeleton, and alters host cellular signaling mechanisms (Hackstadt, 1999; Hatch, 
1999). C. trachomatis infection also disturbs cell-cell contacts between polarized 
epithelial cells in culture (Wyrick et al., 1989). This cell-cell disassociation was later 
shown to be due, at least in part, to disruption of N-cadherin-dependent cell-cell junctions 
and breakdown of the N-cadherin/β-catenin complex (Prozialeck et al., 2002). Notably, 
infected epithelial cell release has also been observed in vivo (Doughri et al., 1972; Soloff 
et al., 1985). Doughri et al further suggest that release of chlamydiae within intact host 
cells might protect the organisms from anti-chlamydial antibodies (Doughri et al., 1972). 
In both studies, the authors hypothesize that PMNs responding to chlamydial infection 
promote detachment of chlamydia-infected cells from the mucosal surface, resulting in 
the release of intact, infected cells into the cervical lumen (Doughri et al., 1972; Soloff et 
al., 1985). The seminal observation that chlamydial infection in the absence of PMNs 
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loosens cell-cell junctions by promoting breakdown of the N-cadherin/β-catenin complex 
(Prozialeck et al., 2002) suggests that the developing chlamydiae may also directly 
contribute to the release of infected cells from the infected mucosa observed in vivo. 
 
In epithelial cells, junctional complexes, which are composed of tight junctions 
(TJs), adherens junctions (AJs), and desmosomes (DSs), play critical roles in forming 
intercellular adhesions. Intercellular adhesions, in turn, are intimately involved in 
maintaining cell structure, transmitting information, regulating cellular migration, and 
imparting strength and rigidity to tissues (Farquhar & Palade, 1963; Gumbiner, 1996; 
Lauffenburger & Horwitz, 1996; Takeichi, 1995). Importantly, the organization and 
function of TJs and DSs are dependent on the formation and maintenance of AJs (Tsukita 
& Furuse, 1999). AJs are located at the basal side of TJs and connect the lateral surfaces 
of adjacent epithelia cells. AJs form complexes with actin and myosin filaments to 
internally brace cells and thereby control their shape. E-cadherin and claudin are two 
well-studied cell-cell adhesion molecules found in AJs and TJs, respectively. 
 
A novel cell-cell adhesion system consisting of nectin and afadin has recently 
been identified at AJs in epithelial cells, neurons, and fibroblasts (Takai & Nakanishi, 
2003). Nectins are Ca2+-independent, Ig-like cell-cell adhesion molecules with three 
extracellular Ig-like loops, a single transmembrane region (except for nectin-1γ) and a 
cytoplasmic tail. The nectin family currently contains 4 members (nectins-1~4) (Sakisaka 
& Takai, 2004; Takai & Nakanishi, 2003). Afadin is a nectin- and F-actin-binding protein 
that connects the trans-membrane domain of nectin to the actin cytoskeleton (Takai & 
Nakanishi, 2003). This nectin-based adhesion system is required not only for the 
formation of AJs but also for the subsequent formation of TJs (Takai & Nakanishi, 2003). 
Furthermore, activation of Cdc42 and Rac small G proteins through c-Src by trans-
interaction of nectins has been implicated in controlling cell-cell adhesion and cell 
polarization (Takai et al., 2003). 
 
In this study, Western blot analyses demonstrate that accumulation of host nectin-
1 is significantly decreased in C. trachomatis serovar E-infected cervical epithelial cells. 
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This down-regulation requires active C. trachomatis protein synthesis and/or replication. 
RT-PCR analyses further show that reduced expression of nectin-1 likely occurs post-
transcriptionally. Because the nectin-afadin adhesion system is critical for formation of 
functional E-cadherin based AJs and subsequent claudin-based TJs, and because 
chlamydial infection has been previously shown to disrupt cell:cell junctions (Prozialeck 
et al., 2002), our data suggest that C. trachomatis may disrupt AJs, at least in part, by 
diminishing nectin-1 expression.  
 
Methods 
 
Cell culture, chlamydial infection and titrations.  
HeLa cells, a human cervical adenocarcinoma epithelial cell line (ATCC No. 
CCL2), were cultured as described (Deka et al, 2006). A human urogenital isolate of C. 
trachomatis E/UW-5/CX was originally obtained from S.P. Wang and C.C. Kuo 
(University of Washington, Seattle, WA). The same standardized inoculum of C. 
trachomatis serovar E EBs, propagated in McCoy cells, was used for all experiments 
(Wyrick et al., 1996). For infection experiments, HeLa cells were either grown in 
standard tissue culture plates or were polarized on 3.0 µm, Collagen IV-coated chamber 
inserts (Biocoat 4544, Becton Dickinson) as described (Wyrick et al., 1989). Host cells 
were infected at a multiplicity of infection (MOI) of 1 using crude EB stock, which 
infects ~ 90% of the HeLa cells, for 1 hour at 35°C. In some experiments, HeLa cells 
were infected with an equivalent amount of UV-inactivated C. trachomatis serovar E (C. 
trachomatis-UV). Mock-infected host cells were treated similarly except they were 
exposed to 200 µl of 2SPG (0.2 M sucrose, 6 mM NaH2PO4, 15 mM Na2HPO4, 5 mM L-
glutamine, pH 7.2). After infection, the inoculum was aspirated and the infected cells 
were refed with growth medium and incubated at 35°C for the indicated times. 
Chlamydial titrations were performed as previously described (Deka et al., 2007). Each 
experiment was repeated three times and each repeat contained three biological replicates.  
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Generation of C. trachomatis-UV.  
A UV cross-linker (Spectrolinker XL1500, Spectronics Corporation) was used to 
generate stocks of UV-inactivated, replication-incompetent C. trachomatis (C. 
trachomatis-UV). Stock C. trachomatis serovar E was thawed on ice and 200 µl was 
aliquoted into each well of a 24-well plate. The plate was placed on a 4ºC heat sink 
during UV exposure to prevent heat inactivation of the samples. EB inactivation was 
assayed by performing chlamydial titrations (Deka et al., 2007). A UV dose of 1.0 J cm-2 
was sufficient to completely inactivate undiluted C. trachomatis stocks (data not shown). 
 
RNA and DNA isolation.  
Total RNA and DNA were isolated from mock- or C. trachomatis-infected HeLa 
cells at 48 hpi and 60 hpi using the method previously described by Deka et al (Deka et 
al., 2006). Total RNA and DNA preparations were quantified by measuring optical 
density (OD) at 260 and 280 nm. All samples had OD260/280 ratios > 1.9.  The quality and 
concentration of each RNA sample were further confirmed by analysis on a 2100 
Bioanalyzer instrument (Agilent) using the RNA 6000 Nano LabChip kit.  All samples 
had RNA Integrity Numbers (RINs) between 9.0-10.0 (data not shown).  
 
PCR, Reverse transcription and RT-PCR.  
Total cellular DNA was used as a template to amplify human glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) for determination of host genome copy number. 
Total cellular RNA samples were subjected to reverse transcription as previously 
described (Deka et al., 2006), except that two micrograms of total RNA was used. RT-
PCR reactions were than carried out using RT(+) and RT(–) cDNA reactions as templates, 
as appropriate. Experimental template DNAs/cDNAs were used in PCR reactions at 
dilutions ranging from 1/10 to 1/1000 (in ddH2O), such that each reaction was in the 
linear amplification range. The amplification conditions were based on those previously 
described (Deka et al., 2006). Published primer sets included human β-actin (Nelson et 
al., 2005) and human GAPDH (Deka et al., 2006). Specific primers and positive 
oligonucleotide amplification controls for human nectin-1α, nectin-1β and nectin-1γ were 
designed using Oligo 4.0 software. They are listed in supplementary Table S1. Most 
 38
reactions were cycled as follows: 94°C, 1 min; 60°C, 1 min; 72°C, 1 min for 35 cycles. 
Human β-actin reactions were performed under identical conditions but were cycled 30 
times; human GAPDH PCR reactions were performed for 35 cycles and annealed at 67°C. 
The resulting PCR products were separated by electrophoresis on 2.5% agarose/TBE gels 
and stained with ethidium bromide.  A Bio-Rad Chemi Doc XRS Image Capture System 
with Quantity One V4.5.0 software was used to visualize and quantify amplimers.  
 
SDS-PAGE and Western blotting.  
Monolayers were lysed and denatured as described (Deka et al., 2006). Samples 
were then normalized for total protein content using SYPRO Ruby stain (BioRad) 
according to the manufacturer’s instructions. Samples were diluted to identical 
concentrations, subjected to SDS-polyacrylamide gel electrophoresis (PAGE), and 
Western blotted (Deka et al., 2006). Primary antibodies used included mouse monoclonal 
anti-nectin-1 CK6 (1:200 dilution, sc-21722, Santa Cruz Biotechnology), mouse 
monoclonal anti-nectin-1 CK8 (1:200 dilution, 37-5900, Invitrogen-Zymed), rabbit 
polyclonal anti-human focal adhesion kinase (FAK) C-20 (1: 2000 dilution, sc-558, Santa 
Cruz Biotechnology), and goat polyclonal anti-MOMP (1:5000 dilution, B65266G, 
BioDesign International). Bound primary antibodies were detected using corresponding 
secondary antibodies conjugated to horseradish peroxidase and visualized using 
SuperSignalWest Pico reagent (Pierce). Specific bands were quantified using an FX 
phosphorimager and Quantity One V2.5.0 software (Bio-Rad). To control for small 
variations in cell number and gel loading between sample lanes, nectin-1 quantity in each 
sample was normalized to the amount of FAK protein detected in that same lane. 
Previous studies from our laboratory have demonstrated that FAK accumulation is not 
altered by chlamydial infection and , therefore, makes an ideal internal control (Deka et 
al., 2006).  
 
Statistical analyses.  
Statistical analyses were performed using Microsoft Excel. A two-sample t-test 
for independent samples was used for comparison of means. Significance was defined as 
P ≤ 0.05. 
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Results 
 
Nectin-1 accumulation is reduced in C. trachomatis-infected HeLa cells.  
Nectin-1 is an important cell-cell adhesion molecule involved in the formation 
and maintenance of AJs and TJs. Previous studies demonstrated that cell:cell contacts are 
disrupted in C. trachomatis-infected cervical epithelial cells (Prozialeck et al., 2002). To 
determine whether chlamydial infection modulates nectin-1 expression, monolayers of 
non-polarized HeLa cells were either mock- or C. trachomatis serovar E-infected at a 
MOI of 1. Cell lysates were collected 48 hpi and processed for SDS-PAGE analyses. 
Duplicate gels were either stained with SYPRO Ruby (data not shown) or Western 
blotted (Fig. 2.1a) using anti-nectin-1 CK6 mAb, anti-C. trachomatis MOMP or anti-
FAK as described (Deka et al., 2006). Nectin-1 bands were quantified, normalized to 
FAK and plotted in Fig. 2.1(b). Focal adhesion kinase (FAK) was chosen as an internal 
control protein because FAK accumulation is not altered by chlamydial infection (Deka 
et al., 2006). As expected, MOMP expression was detected only in C. trachomatis-
infected cells. Nectin-1 accumulation was decreased by up to 85% in C. trachomatis-
infected HeLa cells compared to that in mock-infected controls. Sequential 
immunoprecipitation and blotting experiments with a different nectin-1-specific 
monoclonal antibody (Supplementary Fig. S2.1b) confirmed that the protein detected on 
the blots in Fig. 2.1 was indeed nectin-1. Additionally, little or no nectin-1 was 
immunoprecipitated from chlamydia-infected cells harvested at 48 hpi by either antibody, 
confirming the observations described above. 
 
In vivo, polarized epithelial cells differentially distribute proteins and lipids to the 
plasma membrane, creating two distinct surfaces -- the apical and basolateral domains. 
Previous studies have shown that polarized and non-polarized cells differ in C. 
trachomatis infection efficiency, duration of the C. trachomatis developmental cycle and 
their response to IFN-γ (Arno et al., 1990; Kane & Byrne, 1998; Tam et al., 1992). Thus, 
we wanted to investigate whether or not the polarity of epithelial cells would affect the 
observed nectin-1 reduction. Western blotting analyses (Supplementary Fig.S2.2a) 
showed that nectin-1 was also down-regulated in C. trachomatis-infected polarized cells. 
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At 48 hpi, nectin-1 accumulation was decreased as much as 88% in C. trachomatis-
infected polarized HeLa cells compared to that in mock-infected controls (Supplementary 
Fig. S2.2b). Because similar results were obtained from both non-polarized and polarized 
HeLa cells, non-polarized cells were used in subsequent experiments.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1 Nectin-1 accumulation is reduced in C. trachomatis-infected HeLa cells. HeLa 
cells were either mock- or C. trachomatis serovar E-infected at a MOI of 1. Cell lysates 
were collected 48 hpi and Western blotted using anti-nectin-1 CK6, anti-C. trachomatis 
MOMP or anti-FAK (C-20). Nectin-1 bands were quantified, normalized to the internal 
control protein FAK and plotted in (b). Results are expressed as the average of three 
biological replicates ± SEM. P ≤ 0.05 was considered significant. Groups significantly 
different from the mock-infected controls are indicated by asterisks (*). These data are 
representative of three independent experiments.  
 
 
Nectin-1 accumulation is reduced in C. trachomatis-infected HeLa cells from 36 to 60 
hpi.  
To more precisely define when down-regulation of nectin-1 occurs during the C. 
trachomatis developmental cycle, an infection time course ranging from 0 to 60 hpi was 
conducted. HeLa cells were either mock- or C. trachomatis-infected. Cell lysates were 
collected at 0, 24, 36, 48 and 60 hpi and Western blotted with (i) anti-nectin-1 (CK6), (ii) 
anti-FAK (C-20) and (iii) anti-MOMP. A representative blot is shown in Fig. 2.2(a); the 
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quantification of this blot is shown in Fig. 2.2(b). The nectin-1 quantity observed in C. 
trachomatis-infected cells from three independent experiments was expressed as a 
percentage of that observed in mock-infected control cells at each time interval and 
plotted (Fig. 2.2c). These data demonstrate that C. trachomatis infection significantly 
reduced accumulation of nectin-1 starting at 36 hpi and the reduction was maximal at 60 
hpi.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.2 Nectin-1 accumulation is reduced in C. trachomatis-infected HeLa cells from 
36 to 60 hpi. (a) Cell lysates from mock- or C. trachomatis-infected HeLa cells were 
collected at 0, 24, 36, 48, 60 hpi and Western blotted using anti-nectin-1 CK6, anti-C. 
trachomatis MOMP or anti-FAK (C-20). (b) The quantity of nectin-1 detected in panel (a) 
was normalized to the internal control protein FAK and plotted. (c) Nectin-1 quantity 
observed in C. trachomatis-infected cells was expressed as a percentage of that observed 
in mock-infected control cells at each time interval. Results are expressed as the average 
of three biological replicates ± SEM. P ≤ 0.05 was considered significant. Groups 
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significantly different compared to C. trachomatis-infected cells at 0 hpi are indicated by 
asterisks (*). These data are representative of three independent experiments.  
 
 
Nectin-1 down-regulation requires C. trachomatis protein synthesis and/or replication.  
To extend these findings, we next investigated whether C. trachomatis protein 
synthesis and/or replication was required for nectin-1 down-regulation. Nectin-1 
expression in persistently-infected cells was also examined. HeLa cells were either mock- 
or C. trachomatis-infected and refed immediately after infection with growth medium 
plus ddH2O, medium plus 60 µg chloramphenicol ml-1 (Camp, which specifically inhibits 
function of bacterial 50S ribosomal subunits) or medium plus 20 units penicillin G ml-1 
(PenG, a known inducer of chlamydial persistence).  Cell lysates were harvested at 48 hpi 
for Western blot analyses (Fig. 2.3a, b). Nectin-1 quantity observed in C. trachomatis-
infected cells from three independent experiments was expressed as a percentage of that 
observed in mock-infected control cells under that set of experimental conditions (Fig. 
2.3c). As a control to confirm that each antibiotic was working as expected, duplicate 
cultures from each drug-exposure group were subjected to chlamydial sub-passage 
titration analyses. The number of inclusion-forming units (IFU) in the undiluted inocula 
was then calculated and expressed as IFU ml-1 (Fig. 2.3d). Nectin-1 down-regulation in C. 
trachomatis-infected cells was prevented by chloramphenicol exposure (Fig. 2.3a, lanes 5 
and 6), demonstrating that C. trachomatis protein synthesis and/or replication is required 
for this effect. Nectin-1 levels also decreased in the presence of penicillin G (Fig. 2.3a, 
lanes 7 and 8), although to a lesser degree than that observed in diluent-exposed, 
chlamydiae-infected monolayers (Fig. 2.3b, c). These data indicate that nectin-1 
accumulation can also be reduced by penicillin-induced, persistent C. trachomatis 
infection. Chlamydial sub-passage experiments demonstrate that both chloramphenicol 
and penicillin G exposure significantly reduced recovery of infectious EB, as expected 
(Fig. 2.3d). 
 
 
 
 
 43
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.3 C. trachomatis protein synthesis and/or replication is/are required for nectin-1 
down-regulation. (a) Cells were refed immediately after C. trachomatis-infection with 
growth medium + ddH2O, 60 µg chloramphenicol ml-1 (Camp) or 20 units penicillin G 
ml-1 (PenG).  Cell lysates were harvested at 48 hpi and Western blotted using anti-nectin-
1 CK6, anti-C. trachomatis MOMP or anti-FAK (C-20). (b) The quantity of nectin-1 
detected on the blot in panel (a) was normalized to FAK and plotted. (c) Nectin-1 
quantity observed in C. trachomatis-infected cells was expressed as a percentage of that 
observed in mock-infected control cells under that set of experimental conditions. The 
average from three biologic replicates ± SEM is shown. P ≤ 0.05 was considered 
significant. Groups significantly different compared to Camp-exposed, C. trachomatis-
infected cells are indicated by asterisks (*). (d) Duplicate cell cultures from each drug-
exposure group were subjected to chlamydial sub-passage titration. Results are expressed 
as the average of three biological replicates ± SEM. Significance was defined as P ≤ 0.05. 
Groups significantly different compared to non-drug exposed, C. trachomatis-infected 
cells are indicated by asterisks (*). All data shown here are representative of three 
independent experiments.  
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Viable C. trachomatis EBs are required for nectin-1 down-regulation.  
To determine if viable C. trachomatis EBs are required for down-regulation of 
nectin-1, UV-inactivated C. trachomatis was used to infect HeLa cells. Previous studies 
have demonstrated that UV-inactivation of C. trachomatis renders the bacteria 
completely replication-incompetent (Eissenberg et al., 1983). HeLa cultures were mock-, 
C. trachomatis-, or C. trachomatis-UV-infected, collected at 48 hpi and processed for 
Western blot analyses (Fig. 2.4a). Average nectin-1 accumulation was quantified, 
normalized and plotted (Fig. 2.4b). Nectin-1 accumulation was reduced in C. 
trachomatis-infected cells but not in cultures infected with an equivalent quantity of UV-
inactivated C. trachomatis EB, demonstrating that nectin-1 is down-regulated only if 
cells are infected with viable EBs. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.4 Viable C. trachomatis EBs are required for nectin-1 down-regulation. (a) 
HeLa cells were mock-, C. trachomatis-, or C. trachomatis-UV-infected. Cells were 
collected at 48 hpi and Western blotted using anti-nectin-1 CK6, anti-C. trachomatis 
MOMP or anti-FAK (C-20). (b) The quantity of nectin-1 was normalized to internal 
control protein FAK and plotted. Results are expressed as the average of three biological 
replicates ± SEM.  Significance was defined as P ≤ 0.05. Groups significantly different 
from the mock-infected controls are indicated by asterisks (*).The data shown here are 
representative of three independent experiments.  
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C. trachomatis infection of HeLa cells does not alter accumulation of nectin-1α, β and γ 
transcripts.  
Nectin-1 has three splice variants: nectin-1α, nectin-1β, and nectin-1γ. All three 
nectin-1 isoforms encoded by these transcripts associate with other adhesion molecules 
and play important roles in the formation of cell-cell junctions. Although the nectin-1α 
and nectin-1β proteins both contain the CK6 and CK8-reactive epitopes (Supplementary 
Fig. S2.1a), the observed molecular weight (75kD) is most consistent with the reported 
size for nectin-1α (Struyf et al., 2005) .  To aid in elucidating the mechanism by which 
host cell nectin-1 expression is altered in response to C. trachomatis infection, we 
investigated whether down-regulation of nectin-1 occurs at the transcriptional level. Total 
RNA from mock- or C. trachomatis-infected cells was isolated and subjected to RT-PCR 
using primers specific for human β-actin, nectin-1α, nectin-1β, and nectin-1γ transcripts. 
Parallel total DNA samples were amplified using GAPDH-specific primers to determine 
host genome copy number. All amplimers were the expected size (Fig. 2.5a) and the 
identity of each was confirmed by DNA sequencing (data not shown). In each experiment, 
a six log dilution series of known DNA template controls was used to generate 
amplification standard curves. Experimental samples were only quantified if they fell 
within the linear range of the PCR. Amplification products were not observed in 
template-negative samples (Fig. 2.5a, lane 1) or in RT(-) controls (data not shown). The 
quantity of nectin-1α, β and γ products was similar in mock- compared to C. trachomatis-
infected samples at both 48 and 60 hpi (Fig. 2.5a, lanes 2-5). All amplimers were 
quantified, normalized to host genome copy number as ascertained by PCR with human 
GAPDH-specific primers, and plotted in Fig. 2.5(b). Statistical analyses showed that 
there was no significant difference in accumulation of any of the nectin-1 transcripts in 
mock- versus C. trachomatis-infected cells (Fig. 2.5b). These data indicate that 
expression of nectin-1 was not regulated at the transcriptional level and, thus, was likely 
regulated post-transcriptionally.  
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Figure 2.5 C. trachomatis infection of HeLa cells does not alter accumulation of nectin-
1α, β and γ transcripts. (a) HeLa cells were mock- or C. trachomatis-infected at 1 MOI. 
Total RNA was isolated at 48 or 60 hpi as described and subjected to RT-PCR analyses 
using transcript-specific oligonucleotide probes. Nectin-1α (117bp), Nectin-1β (105bp), 
Nectin-1γ (75bp) and β-actin (230bp) amplimers were electrophoresed and photographed. 
Representative photographs are shown. The position of DNA size markers are shown to 
the left of each gel image in base pairs (bp). (b) Specific DNA amplimers were quantified 
as described. Nectin-1α (black bars), Nectin-1β (grey bars), Nectin-1γ (white bars) and β-
actin (diagonally striped bars) amplimer quantities were normalized to host genome copy 
number as ascertained by PCR with human GAPDH-specific primers (data not shown). 
The values plotted are averages of three independent experiments ± SEM. The value 
obtained for each independent experiment is the average obtained from three biological 
replicates. 
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Discussion 
 
Chlamydiae have evolved various strategies to avoid host defense systems and 
complete their intracellular growth cycle. Chlamydiae have acquired specific mechanisms 
to prevent productively and persistently infected cells from undergoing apoptosis (Dean 
& Powers, 2001; Fan et al., 1998; Fischer et al., 2004; Geng et al., 2000; Pirbhai et al., 
2006; Rajalingam et al., 2001), which may allow chlamydiae to maintain long-term 
survival within infected cells. Chlamydiae also alter host cell:cell contacts and signal 
transduction (Prozialeck et al., 2002; Xia et al., 2003), which may facilitate chlamydial 
growth. Finally, chlamydiae also modify the host cell cytoskeleton (Dong et al., 2004c; 
Majeed et al., 1993), which may benefit chlamydial intravacuolar replication. In the 
present study, we observed a remarkable loss of nectin-1 in C. trachomatis-infected HeLa 
cells. We further demonstrated that active C. trachomatis protein synthesis and/or 
replication and viable C. trachomatis EBs are required for this effect. Lastly, we also 
noted that persistent chlamydial infection, induced by penicillin G, also down-regulates 
nectin-1 accumulation. Because different persistence inducers act upon the developing 
chlamydiae by divergent mechanisms, we must examine other stressors to determine 
whether the nectin-1 decrease is a general characteristic of persistently-infected epithelial 
cells.  
 
It is currently accepted that nectin-1 plays a critical role in the formation and 
maintenance of adherens junctions (AJs) and tight junctions (TJs). Disruption of nectin-1 
would inevitably affect the integrity of cell-cell junctions, which may be implicated in 
chlamydial pathophysiologic effects on the host.  This notion is consistent with a recent 
study showing that cervical epithelial cells separate from each other as a consequence of 
C. trachomatis infection (Prozialeck et al., 2002). Interestingly, the important human 
pathogens Helicobacter pylori, Shigella flexneri, and Salmonella typhimurium also down-
regulate essential components of adhesion and tight junctions, including E-cadherin, 
claudin-1, and ZO-1. This leads to decreased transepithelial electrical resistance and 
increased paracellular permeability, which facilitates cell-to-cell spreading of these 
pathogens (Jepson et al., 1995; Sakaguchi et al., 2002; Sears, 2000; Terres et al., 1998). 
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Collectively, these findings suggest that disruption of adhesion and tight junctions to 
compromise cell-cell barriers may be an important strategy exploited by intracellular 
pathogens to manipulate host cells. Although C. trachomatis serovar E is not an invasive 
pathogen, it may diminish nectin-1 expression to aid lateral cell to cell spread. 
Surprisingly, in contrast to C. trachomatis and the pathogens mentioned above, C. 
pneumoniae up-regulates the expression of adherens junction proteins VE-cadherin, N-
cadherin, and β-catenin and transiently down-regulates the expression of the tight 
junction protein occludin to alter junctional complexes, facilitating its transmission in 
human brain microvascular endothelial cells (MacIntyre et al., 2002). It is currently 
unknown why C. trachomatis and C. pneumoniae might use two distinct mechanisms to 
interact with junctional complexes.  
 
 While nectin-1 protein expression was decreased in C. trachomatis-infected 
HeLa cells, accumulation of nectin-1α, β and γ transcripts was unchanged. These data 
indicate that reduction of nectin-1 was not regulated transcriptionally and, thus, is likely 
down-regulated at the post-transcriptional level. Recently, several host proteins have been 
reported to undergo degradation upon C. trachomatis infection (Balsara et al., 2006; 
Dong et al., 2004c; Dong et al., 2005a; Fischer et al., 2004; Pirbhai et al., 2006; Ying et 
al., 2005; Zhong et al., 1999; Zhong et al., 2000). The chlamydia-secreted protease 
CPAF (chlamydial protease/proteasome-like activity factor) is responsible for the 
degradation of many of these host proteins. Given the broad range of cellular proteins 
cleaved by CPAF, it is possible that CPAF could also degrade nectin-1. Notably, there is 
little or no difference in CPAF expression between productive and persistent infections 
(Heuer et al., 2003; Shaw et al., 2002). Thus, the observation that nectin-1 was decreased 
in both C. trachomatis productively- and persistently-infected samples is consistent with 
the notion that CPAF degrades nectin-1. Alternatively, it is also possible that chlamydial 
infection induces a host cell derived protease or proteosomal activity which degrades 
nectin-1.  The role of CPAF and other chlamydial or host derived proteases in regulating 
nectin-1 accumulation in chlamydiae-infected cells requires further investigation. 
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Although the mechanism by which C. trachomatis down-regulates nectin-1 
expression is of significant interest, a more important question remains--why does C. 
trachomatis reduce host cell nectin-1 accumulation? There are at least two plausible 
hypotheses. First, nectin-1 down-regulation, and subsequent disruption of cell:cell 
adhesions, may facilitate host structural rearrangements required for inclusion 
enlargement or EB release at the end of the developmental cycle. This prediction is 
supported by the observation that nectin-1 accumulation starts decreasing at 36 hpi, 
which is mid-developmental cycle for C. trachomatis serovar E. The second, and perhaps 
more intriguing possibility, is that nectin-1 down-regulation facilitates C. trachomatis 
dissemination within the host genital tract (Supplementary Fig. S3). In this case, 
weakening of contacts between an infected genital epithelial cell and adjacent, uninfected 
cells would allow release of the intact, infected cell into the genital tract lumen. The 
infected cell would then drift away from original infection site in the genital mucus, 
aiding chlamydial dissemination in at least two ways. First, chlamydial EB within the 
exfoliated cell would be shielded from neutralization by secretory IgA, cationic anti-
microbial peptides (CAMPs) and other anti-bacterial compounds, as long as the host cell 
remained intact. Second, if the infected cell ruptured in close proximately to the genital 
mucosa, the local concentration of infectious EB would be very high, increasing the 
probability that mucosal epithelia in the vicinity would be successfully infected. In 
contrast, EB released from host cells still within the genital epithelial layer 
(Supplementary Fig. S3, right) would be both quickly diluted and immediately subject to 
neutralization by anti-bacterial compounds. Therefore, only host cells in close proximity 
to the release site would have a high probability of becoming infected. Thus, we envision 
that the released, inclusion-containing epithelial cell would act like a chlamydial “cluster 
bomb”, allowing delivery of a concentrated inocula over a relatively long distance and 
increasing the possibility of a “hit” if the host cell ruptured near the genital epithelial cell 
layer. Interestingly, release of intact, chlamydiae-infected host cells has been observed 
from polarized monolayers in culture (Wyrick et al., 1989) as well as from infected 
epithelium in vivo (Doughri et al., 1972; Soloff et al., 1985). Of course, it is always 
possible that the observed nectin-1 decrease is an indirect side-effect of other host 
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cytoskeletal or physiologic alterations induced during chlamydial infection. Future 
studies will be directed toward determining which of these hypotheses are correct.  
 
Finally, it should be noted that nectin also plays a critical role in intracellular 
signaling. Recent studies have demonstrated that Cdc42 and Rac small G proteins are 
activated by trans-interactions of nectin in a PI3 kinase-independent manner in epithelial 
cells (Honda et al., 2003; Kawakatsu et al., 2002). Although the precise mechanisms of 
this activation remain to be elucidated, Cdc42 and Rac activities are required for the 
formation and maintenance of AJs in epithelial cells (Braga et al., 1997; Braga et al., 
1999; Etienne-Manneville & Hall, 2002; Takaishi et al., 1997; Van Aelst & Symons, 
2002). It is reasonable to speculate that the disruption of cell-cell junctions observed by 
Prozialeck et al (Prozialeck et al., 2002) upon C. trachomatis infection may result from 
insufficiently activated Cdc42 and Rac in response to reduced levels of nectin-1. 
Furthermore, activated Cdc42 and Rac stimulate the c-Jun N-terminal kinase (JNK) 
signaling pathway (Honda et al., 2003), which has been implicated in regulating cell 
growth, transformation and apoptosis (Johnson & Lapadat, 2002; Lin, 2003). As 
previously discussed, chlamydial infection strongly inhibits host cell apoptosis and it is 
possible that reduced nectin-1/JNK signaling may play a role in this inhibition. Given the 
known interplay between nectin-1 and host cellular signaling pathways, dissecting the 
effect of C. trachomatis infection on nectin-mediated signal transduction events will be a 
key aspect of future experiments. 
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Supplementary Material 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplementary Figure 2.1 Nectin-1 antibodies CK6 and CK8 detect the same protein. 
Mock- (lanes 1, 3 and 5) or C. trachomatis-infected (lanes 2, 4 and 6) HeLa monolayers 
were harvested at 48 hpi in 1X IP lysis buffer (Saltarelli et al., 1993). Cell lysates were 
homogenized by passing them through a 20-gauge needle 10 times and were quantified 
using a Bradford protein assay. Equivalent amounts of protein from each lysate were 
immunoprecipitated using either nectin-1-specific mAb CK6 (lanes 1 and 2), nectin-1-
specific CK8 mAb (#37-5900, Invitrogen-Zymed; lanes 3 and 4) or protein A beads alone 
(#17-0974-01, Amersham Pharmacia Biotechnology; lanes 5 and 6). These antibodies 
recognize two overlapping linear epitopes between nectin-1 amino acids 80 and 104 [Fig. 
S2.1a, boxed sequence (Krummenacher et al., 2000)]. Immunoprecipitates were then 
boiled for 10 min, electrophoresed and then Western blotted using either CK6 (Fig. S2.1b, 
left panel) or CK8 (Fig. S2.1b, right panel) to detect nectin-1. Both CK6 and CK8 mAbs 
immunoprecipitated identically sized 75kD proteins from mock-infected cells but not 
from C. trachomatis-infected cells (Fig. S2.1b), confirming that this protein was indeed 
nectin-1. Additionally, little or no nectin-1 is immunoprecipitated from chlamydia-
infected cells, which is consistent with previous observations. The 50 and 25 kD bands 
are heavy and light chains from the immunoprecipitating antisera that are detected by the 
anti-mouse secondary antibody. The data shown here are representative of three 
independent experiments.  
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Supplementary Figure 2.2 Nectin-1 accumulation is reduced in C. trachomatis-infected 
polarized HeLa cells. Polarized HeLa cells were either mock- or C. trachomatis serovar 
E-infected at an MOI of 1. Cell lysates were collected 48 hpi and Western blotted using 
anti-nectin-1 CK6, anti-C. trachomatis MOMP or anti-FAK (C-20). Nectin-1 bands were 
quantified, normalized to the internal control protein FAK and plotted in (b). Results are 
expressed as the average of three biological replicates ± SEM. P ≤ 0.05 was considered 
significant. Groups significantly different from the mock-infected controls are indicated 
by asterisks (*). These data are representative of three independent experiments. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplementary Figure 2.3 Potential role of nectin-1 down-regulation in C. trachomatis 
dissemination within the host genital tract. See the text for a detailed description of the 
figure. Red dots represent EBs; green circles represent RBs. 
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Supplementary Table S2.1. RT-PCR primers and positive control oligonucleotides. 
 
Name Forward primer Reverse primer 
hNectin-1α AGCACCAAGAAGCACGTGTA GGCCTTCTTCTCGTCGTCT 
hNectin-1β CCCAGCAGGCAAAGC TC CAGGGACAGCTTCTGCAAGT 
hNectin-1γ GCATGGGCTTGATGTCAG TCATACTGTCCCCGTTTTACA 
 
hNectin-1α 
positive 
control oligo 
 
AGCACCAAGAAGCACGTGTATGGCAACGGCTACAGCAAGGCA
GGCATCCCCCAGCACCACCCACCAATGGCACAGAACCTGCAG
TACCCCGACGACTCAGACGACGAGAAGAAGGCC 
 
hNectin-1β 
positive 
control oligo 
CCCAGCAGGCAAAGCTCCCTTGTGCCTGAGGATATCCAGGTTG
TCCACCTGGACCCAGGGAGGCAGCAGCAGCAAGAAGAGGAGG
ACTTGCAGAAGCTGTCCCTG 
 
hNectin-1γ 
positive 
control oligo 
GCATGGGCTTGATGTCAGACAGCTGTGACCCTGGACAGGGCCC
CCCCCACCATCTGTAAAACGGGGACAGTATGA 
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Abstract 
 
Nectin-1 is an adhesion protein implicated in the organization of adherens junctions and 
tight junctions in epithelial cells. Previous studies in our laboratory demonstrated that 
nectin-1 accumulation was significantly decreased in Chlamydia trachomatis-infected 
HeLa cells. In the present study, Western blot analyses indicated that nectin-1 down-
regulation was C. trachomatis concentration-dependent. The half life of nectin-1 was also 
greatly diminished in C. trachomatis-infected cells compared to that observed in mock-
infected cells, indicating that nectin-1 was likely down-regulated post-translationally. The 
chlamydia-secreted protease CPAF is known to degrade several important host proteins; 
CPAF expression within infected cells correlated with the time-dependent cleavage of 
nectin-1. Notably, CPAF proteolytic activity is inhibited by lactacystin but not by the 
proteosome inhibitor MG132. In vivo inhibition experiments demonstrated that nectin-1 
down-regulation was blocked by lactacystin exposure. In contrast, MG132 had no effect. 
Finally, cell-free cleavage assays demonstrated that functional recombinant GST-CPAFwt 
protein degrades nectin-1. This degradation was blocked by lactacystin, as previously 
observed in vivo. Collectively, these results indicate that nectin-1 is degraded by CPAF 
in C. trachomatis-infected cells, a novel strategy that chlamydiae may use to aid their 
dissemination. 
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Introduction 
 
Chlamydia trachomatis is a Gram-negative, obligate intracellular bacterium that is 
one of the leading causes of sexually transmitted disease and the most common cause of 
preventable blindness worldwide. Long-term C. trachomatis genital tract infections are 
often chronic and asymptomatic, leading to severe complications including epididymitis 
and prostatitis in men as well as pelvic inflammatory disease, ectopic pregnancy and 
infertility in women (Darville, 2000a). C. trachomatis alternates between two 
morphologically distinct forms and has a unique biphasic developmental cycle. This 
cycle begins when infectious but metabolically inactive elementary bodies (EB) bind to 
and enter mucosal epithelial cells. Once internalized, the EBs remain within a membrane-
bound inclusion and transform into non-infectious but metabolically active reticulate 
bodies (RB). Using nutrients from host cell, the RBs multiply, divide by binary fission 
and eventually differentiate back into EBs, which are then released from the host cell 
(Wyrick, 2000).  
 
To ensure their successful intracellular replication and long-term survival within 
infected hosts, chlamydiae have developed various strategies to evade host defense 
systems. Recently, a chlamydia-secreted protein, designated chlamydia protease-like 
activity factor (CPAF), has been identified. CPAF is hypothesized to play important roles 
in promoting chlamydial replication and protecting infected cells from host immune 
detection (Dong et al., 2004c; Kawana et al., 2007; Pirbhai et al., 2006; Zhong et al., 
1999; Zhong et al., 2000; Zhong et al., 2001). CPAF is synthesized in chlamydial 
inclusions and subsequently secreted into the cytoplasm of infected host cells (Fan et al., 
2002; Zhong et al., 2001). CPAF is initially produced as an inactive proenzyme of ~70 
kDa and rapidly processed into two fragments, a 35 kDa C-terminal portion (CPAFc) and 
a 29 kDa N-terminal portion (CPAFn), which must form intramolecular dimers to acquire 
proteolytic activity (Dong et al., 2004a; Dong et al., 2004b; Zhong et al., 2001). 
Furthermore, the proteolytic activity of CPAF is inhibited by the cytosolic proteasome 
inhibitor lactacystin but not by other proteasome inhibitors such as MG132 and MG115 
or by broad spectrum protease inhibitors such as PMSF and pepstatin A (Zhong et al., 
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2000; Zhong et al., 2001). Moreover, CPAF is responsible for degrading host 
transcription factors USF-1 and RFX5, required for host cell major histocompatibility 
complex (MHC) class І and ІІ antigen activation (Zhong et al., 1999; Zhong et al., 2000). 
Similarly, CPAF was found to be both necessary and sufficient for cleaving keratin 8 
(Dong et al., 2004c), pro-apoptotic BH3-only proteins (Pirbhai et al., 2006), and CD1d 
glycoprotein (Kawana et al., 2007). Keratin 8 is a key subunit of intermediate filaments 
and cleavage of keratin 8 may facilitate chlamydial replication by increasing the 
solubility of intermediate filaments (Dong et al., 2004c). Pro-apoptotic BH3-only 
proteins are required for apoptosis in response to cytotoxic stimuli or exogenous stress, 
and they function by neutralizing their pro-survival counterparts or activating pro-
apoptotic Bcl-2 family members Bax and Bak (Bouillet & Strasser, 2002). Degradation of 
BH3-only proteins contributes to chlamydial anti-apoptotic activity which may help 
chlamydiae evade CTL-mediated host cell apoptosis induction and, thus, benefit long-
term survival of chlamydiae in infected hosts (Pirbhai et al., 2006). CD1d is an MHC-like 
glycoprotein that presents lipid antigen to natural killer T cells. Down-regulation of 
CD1d may help C. trachomatis escape detection by the host innate immune system 
(Kawana et al., 2007).  
 
Previous studies in our laboratory have demonstrated that accumulation of the 
host adherens junction molecule nectin-1 is significantly decreased in C. trachomatis 
serovar E-infected cervical epithelial cells at a post-transcriptional level (Sun et al., 2008). 
Nectin-1, a member of the nectin family, is a Ca2+-independent cell adhesion molecule 
(CAM) with three extracellular Ig-like loops, a single transmembrane domain and a 
cytoplasmic region (Takai & Nakanishi, 2003). Nectins are intimately involved in 
formation of cell-cell adhesions, which subsequently, in cooperation with other CAMs, 
function in formation and maintenance of adherens junctions (AJs) and tight junctions 
(TJs) between neighboring epithelial cells. Using the nectin-based adhesion system, AJs 
stabilize the epithelium and establish apical-basal polarity of epithelial cells. Additionally, 
nectins regulate activities of Rho small GTPases and subsequently modulate epithelial 
barrier functions through reorganization of the actin cytoskeleton and the integrity of 
intercellular junctions (Braga, 2002). Given the broad range of cellular proteins that are 
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CPAF targets, we hypothesized that CPAF may degrade nectin-1 in C. trachomatis-
infected genital epithelial cells. Because nectin-1 is very important for formation and 
maintenance of AJs and TJs in epithelial cell layers, CPAF-mediated nectin-1 
degradation could weaken contacts between an infected genital epithelial cell and 
adjacent, uninfected cells. This would allow release of the intact, infected cells into 
genital tract lumen, facilitating chlamydial dissemination within genital tract and aiding 
establishment of ascending genital tract infection. 
 
Materials and methods 
 
Cell culture and chlamydial infection. 
HeLa cells, a human cervical adenocarcinoma epithelial cell line (ATCC No. 
CCL2), were maintained at 37 °C in Minimal Essential Medium (MEM, Gibco) with 
Earle's salts and L-glutamine supplemented with 10 % fetal calf serum (Atlanta 
Biologicals) in an atmosphere of 5 % CO2  and 95 % humidified air.  C. trachomatis 
LGV2 (L2) was used to generate purified CPAF for cell-free cleavage assays. C. 
trachomatis E/UW-5/CX was used for the rest of the experiments. Standardized inocula 
of C. trachomatis E were propagated in McCoy cells as previously described (Wyrick et 
al., 1996; Zhong et al., 1988). C. trachomatis was used to infect HeLa cells as described 
previously (Sun et al., 2008). Unless otherwise indicated, a multiplicity of infection (MOI) 
of 1 was used.  
 
Indirect immunofluorescence assay. 
HeLa cells were cultured on glass coverslips in 24-well plates overnight and then 
either mock- or C. trachomatis E-infected as described (Sun et al., 2008). After various 
time periods, the samples were fixed with 100% pre-cooled methanol at −20 °C for 
10 min, followed by a brief rinse with 1x PBS. Fixed cells were then blocked for 45 min 
at 25 °C in 1x PBS containing 15 % FBS. After blocking, some fixed samples were 
incubated with anti-nectin-1 CK6 (1:50 dilution, sc-21722, Santa Cruz Biotechnology) 
and anti-C. trachomatis major outer membrane protein (MOMP; 1:200 dilution, 
B65266G, Meridian Life Sciences). The other fixed samples were incubated with either 
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anti-CPAFn (1:10 dilution, recognizing N terminus fragment of CPAF, a kind gift from 
Dr. G.M. Zhong, University of Texas, San Antonio, TX) or anti-MOMP antibodies. 
These incubations were carried out for 1 h at 25 °C. Samples were then stained with 
Alexa fluor 488 donkey anti-mouse IgG (1:1000 dilution for nectin-1 and 1:500 dilution 
for CPAFn, A21202, Invitrogen) or Texas red-conjugated donkey anti-goat IgG (1:200 
dilution, 59820, Jackson ImmunoResearch Laboratories) for 1 h at 25 °C. Between 
incubations, the samples were washed twice with 1x PBS. After the final washes, the 
samples were rinsed with distilled H2O and mounted onto a glass slide using mounting 
medium (M01, Biomeda Corp). The following controls were included to confirm the 
specificity of nectin-1 or CPAF staining: i) primary antibody alone and ii) secondary 
antibody alone. Images were captured at 400 x using a Zeiss Axiovert S100 inverted 
microscope and Axiocam camera. Alexa fluor 488-labeled cells were photographed using 
a FITC-band pass filter; Texas red-labeled cells were photographed using a Rhodamine-
long pass filter. Color images were converted to grayscale for publication using Adobe 
Photoshop. 
 
Western blotting. 
Monolayers of HeLa cells were lysed and denatured as described by Deka et al. 
(Deka et al., 2006). The Western blot assays were performed as described previously 
(Sun et al., 2008). Briefly, samples were quantified and normalized for total protein 
content by SDS-polyacrylamide gel electrophoresis (PAGE) followed by SYPRO Ruby 
staining (BioRad) according to the manufacturer’s instructions. Samples were diluted to 
identical concentrations, requantified as above to confirm that the relative concentration 
were the same and subjected to SDS-PAGE and Western blotting (Deka et al., 2006). 
Primary antibodies used for Western blotting included mouse monoclonal anti-nectin-1 
CK6 (1:200 dilution), mouse monoclonal anti-β-actin (1:5000 dilution, MAB1501, 
Chemicon), mouse monoclonal anti-CPAFn (1:1000 dilution), mouse monoclonal anti-
cytokeratin-8 (1:5000 dilution, C-5301, Sigma), and goat polyclonal anti-MOMP (1:5000 
dilution). Primary antibody binding was detected with corresponding secondary 
antibodies conjugated to horseradish peroxidase. Specific bands were quantified using an 
FX phosphorimager and Quantity One V2.5.0 software (Bio-Rad). To control for small 
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variations in cell number and gel loading between sample lanes, nectin-1 quantity in each 
sample was normalized (Deka et al., 2006; Sun et al., 2008) to the amount of β-actin 
protein detected in that same lane. Previous studies from our and other laboratories have 
demonstrated that β-actin protein accumulation is not altered by chlamydial infection and, 
therefore, makes an ideal internal control (Deka et al., 2006) 
 
In vivo proteasome inhibitor treatment. 
Monolayers of HeLa cells were either mock- or C. trachomatis E-infected. At 24 
h post infection (hpi), either dimethyl sulfoxide (DMSO, diluent control), lactacystin (30 
µM in DMSO, no. 426102, Calbiochem) or MG132 (30 µM in DMSO, no. 474790, 
Calbiochem) was added to the cell cultures as indicated. Cell lysates were collected at 48 
hpi and processed for Western blot analyses using anti-nectin-1 and anti-β-actin 
antibodies. Duplicate cell cultures were assayed using the live/dead assay kit (Molecular 
Probes) to assure that any decrease in protein expression observed is not due to toxicity 
of the inhibitors. 
 
Cell-free cleavage assays. 
The cell-free cleavage assays were carried out as previously described (Zhong et 
al., 2001). Briefly, cytosolic extracts (CE) containing target proteins keratin 8 and nectin-
1 were prepared and used as substrate. The enzyme sources included C. trachomatis L2-
infected HeLa cell cytosolic extracts (L2S100) containing natural CPAF, a functional 
recombinant GST-CPAFwt fusion protein, and the inactive recombinant GST-CPAFD502A 
mutant at the concentrations listed in the Figure 5 legend (kind gifts from Dr. G. M. 
Zhong, University of Texas, San Antonio, TX). The cytosolic extracts were made as 
described (Dong et al., 2004c) by extracting 1x107 mock- or C. trachomatis-infected 
HeLa cells with 1 ml of a buffer containing 1 % NP-40, 0.5 % Triton X-100 and 150 mM 
NaCl in 50 mM Tris (pH 8.0) plus a protease inhibitor cocktail (Sigma). The enzyme was 
mixed with the substrate in the presence or absence of inhibitor lactacystin (Calbiochem). 
All reactions were carried out at 37 °C for 1.5 h and then subjected to Western blot 
analyses using anti-nectin-1 and anti-keratin 8 antibodies.  
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Statistical analyses. 
All experiments were repeated three times and each repeat contained three 
biological replicates, with exception of cell-free cleavage assays which were repeated 
twice. Statistical analyses were performed using Microsoft Excel. A two-sample t test for 
independent samples was used for comparison of means; p-values ≤ 0.05 were considered 
significant.  
 
Results 
 
Nectin-1 down-regulation is C. trachomatis concentration-dependent. 
Previous studies in our laboratory demonstrated that host nectin-1 accumulation 
was decreased by up to 85 % in C. trachomatis-infected HeLa cells. Nectin-1 down-
regulation also required active C. trachomatis protein synthesis and replication (Sun et al., 
2008). The obvious next question was: does a chlamydial factor down-regulate nectin-1 
in infected cells? Previous infection studies (Sun et al., 2008) were performed at 1 MOI, 
which infects 80-90% of HeLa cells in monolayer culture. To determine whether nectin-1 
was down-regulated in a dose-response manner, triplicate monolayers of HeLa cells were 
either mock-infected or infected with different concentrations of C. trachomatis E as 
indicated. Cell lysates were collected at 60 hpi and processed for SDS-PAGE analyses 
(Fig. 3.1A, B). Duplicate gels were either Sypro Ruby stained for total protein 
quantification (data not shown) or Western blotted (Fig. 3.1A) using anti-nectin-1 CK6 
mAb or anti-β-actin mAb, as described previously (Deka et al., 2006). Nectin-1 bands 
were quantified, normalized to the β-actin internal control protein, and plotted in Fig. 
3.1B. As shown in Fig. 3.1A, compared to mock-infected HeLa cell cultures, nectin-1 
accumulation was significantly reduced in HeLa cell cultures infected with C. 
trachomatis at an MOI of 1 or 0.5 inclusion forming units/cell. In contrast, infection with 
lower quantities of C. trachomatis (0.25 and 0.125 MOI) did not significantly reduce 
nectin-1 accumulation. These data clearly demonstrate that nectin-1 down-regulation 
within infected cells is C. trachomatis concentration-dependent. 
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Figure 3.1 Nectin-1 down-regulation is C. trachomatis concentration-dependent.  (A) 
HeLa cells were either mock-infected or infected with different concentrations of C. 
trachomatis serovar E. Cell lysates were collected at 60 hpi and Western blotted using 
anti-nectin-1 (CK6) and anti-β-actin. (B) Nectin-1 bands were quantified and normalized 
to the β-actin internal control and plotted. Results are expressed as the mean ± SEM of 
three biological replicates. Those data points significantly different from mock-infected 
controls are indicated by asterisks (P ≤ 0.05). (C) HeLa cells were cultured on coverslips 
and C. trachomatis serovar E-infected at 0.25 MOI. After 48 h, cells were fixed and 
subjected to IFA with nectin-1 and MOMP antibodies. Images were captured at 400 x. 
All data shown are representative of three independent experiments.   
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To confirm that nectin-1 was decreased only in C. trachomatis-infected cells, we 
employed indirect immunofluorescence (IFA) methodology. HeLa cells were cultured on 
coverslips and C. trachomatis-infected at an MOI of 0.25 to assure that both uninfected 
and infected cells would be visible within a single microscopic field. After 48 h, cells 
were fixed and double-stained with nectin-1 and MOMP specific antibodies. As expected, 
MOMP was detected in a small number of C. trachomatis-infected HeLa cells (Fig. 3.1C, 
right panel, white arrows). Interestingly, nectin-1 was visible in uninfected cells but was 
not observed in C. trachomatis-infected HeLa cells (Fig. 3.1C, left panel, white arrows). 
These data indicate that nectin-1 accumulation was only decreased in C. trachomatis-
infected HeLa cells.  
 
The half-life of nectin-1 in C. trachomatis-infected cells is much shorter than that 
observed in mock-infected cells. 
To determine whether nectin-1 might be subject to C. trachomatis-mediated 
proteolytic degradation, we next determined the half-life of nectin-1 in mock- and C. 
trachomatis-infected HeLa cells. Triplicate monolayers of HeLa cells were either mock- 
or C. trachomatis-infected at an MOI of 1 and then incubated in growth medium plus 2 
µg/ml cycloheximide, which halts eukaryotic but not C. trachomatis protein synthesis. 
Pulse chase experiments in which HeLa cells were incubated in 35S-methionone-
containing medium demonstrated that host protein synthesis is inhibited by >95% under 
these conditions {(Deka et al., 2007) and unpublished results}. Previous studies in our 
laboratory demonstrated that C. trachomatis infection first significantly reduced nectin-1 
accumulation at 36 hpi. The observed reduction was maximal at 60 hpi (Sun et al., 2008). 
Therefore, cell lysates were collected for half-life analyses beginning at 36 hpi (mid-
development) and extending into the late-developmental cycle (50 and 57 hpi). Samples 
were Western blotted (Fig. 3.2A) and both nectin-1 and β-actin bands were quantified 
and plotted. These plots were subsequently used to calculate the half-life of each protein 
in mock- and C. trachomatis-infected cells (Fig. 3.2B, C). The half-life of nectin-1 in C. 
trachomatis-infected cells was much shorter (~ 7 h) than that observed in mock-infected 
cells (> 62 h; data not shown). These data strongly suggest that nectin-1 is down-
regulated by proteolytic degradation in C. trachomatis-infected cells. 
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Figure 3.2 The half-life of nectin-1 in C. trachomatis-infected cells is much shorter than 
that observed in mock-infected cells. HeLa cells were mock- or C. trachomatis-infected 
at 1 MOI with addition of 2 µg/ml cycloheximide. Cell lysates were collected at 36, 43, 
50 and 57 hpi and processed for Western blot analysis as described (Fig. 3.2A). Nectin-1 
and β-actin bands were plotted in Fig. 3.2B and C using Minitab 15 statistical software. 
The half-life of nectin-1 in mock- or C. trachomatis-infected cells was calculated from 
the plots in Fig. 3.2B and C, respectively. The means of three biologic replicates from 
three independent experiments are shown.  
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CPAF expression correlates with C. trachomatis infection time-dependent cleavage of 
nectin-1. 
Published studies and the data presented above suggested that a previously 
identified chlamydial protease (CPAF) might be responsible for cleaving nectin-1. To test 
this possibility, we first examined whether CPAF expression kinetics correlate to the 
timing of nectin-1 cleavage in C. trachomatis-infected cells. HeLa cells were either 
mock- or C. trachomatis-infected and duplicate cell cultures were collected at 0 and 24 
hpi (early development), 36 hpi {mid-development when significant nectin-1 degradation 
is first observed (Sun et al., 2008)} as well as at 48 and 60 hpi (late development). Cells 
were either: i) fixed for IFA (Fig. 3.3A) and stained with anti-CPAFn and anti-MOMP or 
ii) processed for Western blotting (Fig. 3.3B). Western blots were probed using: i) anti-
CPAFn, ii) anti-nectin-1 CK6, iii) anti-MOMP and iv) anti-β-actin. As previously 
observed (Sun et al., 2008), C. trachomatis infection significantly decreased nectin-1 
accumulation from 36 to 60 hpi (Fig. 3.3B). CPAF was first detected at 24 hpi by IFA 
(Fig. 3.3A) and 36 hpi by Western blotting (Fig. 3.3B); with maximal expression at 60 
hpi. These data indicate that CPAF expression within infected cells correlates well with 
the timing of nectin-1 cleavage. 
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Figure 3.3 CPAF expression correlates with the C. trachomatis infection time-dependent 
cleavage of nectin-1. Duplicate cell cultures were collected at 0, 24, 36, 48 and 60 hpi 
and either fixed for IFA by staining with anti-CPAFn or anti-MOMP (A) or processed for 
Western blot analyses using: (i) anti-CPAFn, (ii) anti-nectin-1 (CK6), (iii) anti-MOMP 
and (iv) anti-β-actin (B). IFA images were captured at 400×. Phase contrast images of 
stained and non-stained cells are also shown. The data shown are representative of three 
independent experiments. 
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Nectin-1 down-regulation in C. trachomatis-infected cells is inhibited by the proteasome 
inhibitor lactacystin but not by MG132. 
The proteolytic activity of CPAF is inhibited by lactacystin, an irreversible 
proteasome inhibitor, but not by the similar proteosomal inhibitor MG132 (Zhong et al., 
2001). Therefore, we examined nectin-1 accumulation in C. trachomatis-infected HeLa 
cells exposed to either lactacystin or MG132. Triplicate monolayers of HeLa cells were 
either mock- or C. trachomatis-infected. At 24 hpi, growth medium plus either DMSO 
(diluent control), lactacystin (30 µM in DMSO) or MG132 (30 µM in DMSO) was added 
to each culture as indicated in Fig 3.4A. Cell lysates were collected at 48 hpi and 
processed for Western analyses (Fig. 3.4A). Nectin-1 bands were quantified, normalized 
to the β-actin control and plotted in Fig. 3.4B. As expected, nectin-1 accumulation was 
significantly decreased in C. trachomatis-infected and C. trachomatis plus DMSO-
infected samples. Notably, down-regulation of nectin-1 was blocked by lactacystin-
exposure but not by MG132 (Fig. 3.4B), strongly suggesting that CPAF, rather than the 
host proteosome, mediates the observed down-regulation of nectin-1 in C. trachomatis-
infected HeLa cells.  
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Figure 3.4 Down-regulation of nectin-1 in C. trachomatis-infected HeLa cells is inhibited 
by the cytosolic proteasome inhibitor lactacystin but not by MG132. HeLa cells were 
either mock- or C. trachomatis-infected as described in Fig. 3.2. DMSO (diluent control), 
lactacystin (30 µM) or MG132 (30 µM) was added to cell cultures at 24 hpi. Cell lysates 
were collected at 48 hpi and processed for Western blot analyses as described. Nectin-1 
bands were quantified, normalized to the β-actin internal control and plotted in Fig. 3.4B. 
Results are expressed as the mean ± SEM of three biological replicates. Those data 
significantly different from the mock-infected controls are indicated by asterisks (P ≤ 
0.05). All data are representative of three independent experiments.  
 
 
CPAF is sufficient for nectin-1 degradation in a cell-free assay. 
To evaluate whether CPAF alone is sufficient to degrade nectin-1 in C. 
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from E. coli was used to cleave nectin-1 in cell-free, in vitro cleavage assays (Fig. 3.5). 
As a positive control for CPAF activity, the blots were also probed for keratin 8, which is 
degraded by both natural CPAF present in C. trachomatis L2-infected cell cytosolic 
extract (L2S100) and the GST-CPAFwt fusion protein (Dong et al., 2004a). Notably, 
L2S100 (a kind gift from Dr. G. Zhong) degraded both nectin-1 and keratin 8 in these 
assays (Fig. 3.5, lane 2). As expected, degradation of nectin-1 and keratin 8 by L2S100 
extract was reduced when lactacystin was added (Fig. 3.5, lane 3). More importantly, 
purified recombinant GST-CPAFwt protein (a kind gift from Dr. G. Zhong) also cleaved 
nectin-1 in a concentration dependent manner (Fig. 3.5, lanes 4-6). Again, lactacystin 
reduced GST-CPAFwt activity on nectin-1 (Fig. 3.5, lane 7), as previously observed in 
vivo. Collectively, these observations indicate that nectin-1 degradation is not mediated 
by the host proteosome or proteolytic enzymes and demonstrate that CPAF activity is 
sufficient for the nectin-1 degradation observed in C. trachomatis-infected HeLa cells. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.5 CPAF is sufficient for degrading nectin-1. A cell-free cleavage assay was 
performed using: i) C. trachomatis serovar L2-infected cell cytosolic extract (L2S100) 
which contains natural CPAF (0.0235 µM), ii) a functional recombinant GST-CAPFwt 
fusion protein expressed in E. coli and iii) the E. coli-expressed, recombinant inactive 
GST-CPAFD502A mutant. The components in each reaction, as well as the amount of each 
component, are listed above each lane in Fig. 3.5. Reactions in lanes 4 and 8 contained 
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0.33 µmol of either GST-CAPFwt or GST-CPAFD502A. Other reactions contained either 
1.33 µmol (lanes 5 and 9) or 5 µmol (lanes 6, 7, 10 and 11) respectively.  Cytosolic 
extract (CE) from mock-infected HeLa cells provides the substrates for CPAF-cleavage, 
including nectin-1 and keratin-8. All reactions were incubated at 37 °C for 1.5 h and then 
subjected to Western blot analyses using anti-nectin-1 (CK6) and anti-keratin-8. The data 
are representative of two independent experiments.  
 
 
 
Discussion 
 
Chlamydiae are obligate intracellular bacteria that progress through their 
developmental cycle within an inclusion in the eukaryotic host cell. In order to survive 
and successfully replicate, chlamydiae have evolved a variety of strategies to cope with 
the harsh intracellular environment, such as avoiding fusion with lysosomes (Ojcius et al., 
1998), prevention of  host cell apoptosis (Fan et al., 1998), and altering host cell signal 
transduction (Xia et al., 2003). A chlamydia-secreted protease, termed CPAF, degrades a 
number of host cell proteins during chlamydial infection, including transcription factors 
RFX5 and USF-1, keratin 8, pro-apoptotic BH-3 only proteins, and CD1d glycoprotein. 
Thus, CPAF activity may contribute to chlamydial anti-apoptotic activity, evasion of host 
immune detection and modification of host cell cytoskeleton (Dong et al., 2004c; 
Kawana et al., 2007; Pirbhai et al., 2006; Zhong et al., 2000). 
 
Previous studies in our laboratory demonstrated that nectin-1, a key host cellular 
adhesion protein, is significantly down-regulated in C. trachomatis-infected HeLa cells at 
a post-transcriptional level (Sun et al., 2008). In the current study, we focused on 
elucidating the molecular mechanism(s) by which chlamydiae down-regulate nectin-1. 
Collectively, our observations have led us to conclude that CPAF is both necessary and 
sufficient for nectin-1 degradation. Interestingly, several studies of other human 
pathogens suggest that disruption of cell-cell junctions is an important strategy to help 
intracellular pathogens to spread from cell to cell. Helicobacter pylori, a major etiological 
agent in peptic ulcer disease, decreases host cell E-cadherin, an essential protein for 
maintenance of AJs (Terres et al., 1998), and alters distribution of ZO-1, a key TJ 
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scaffolding protein (Krueger et al., 2007). Shigella flexneri, an important cause of acute 
bacillary dysentery in humans, reduces functional components of TJs, including ZO-1, 
ZO-2, and claudin-1 in infected intestinal epithelial cells (Sakaguchi et al., 2002). These 
alterations, triggered by pathogen infection, are associated with decreased transepithelial 
electrical resistance (TER) and increased paracellular permeability, which subsequently 
result in elongated host cell phenotype and increased migration. As described before, 
nectin-1 is a key component of AJs and plays critical roles in formation and maintenance 
of AJs and TJs. Down-regulation of nectin-1 by CPAF would be expected to reduce the 
integrity and strength of AJs and TJs, leading to loosening of adjacent cell-cell junctions. 
Relaxation of cell:cell adhesions may allow C. trachomatis to rearrange host cell 
structures required for inclusion enlargement or for EB release at the end of the 
developmental cycle. On the other hand, disruption of cell-cell junctions may facilitate C. 
trachomatis dissemination within infected host genial tract by allowing release of intact C. 
trachomatis-infected cells from epithelial monolayers. This prediction is consistent with 
previous observations that cervical epithelial cells separate from each other as a 
consequence of C. trachomatis infection (Prozialeck et al., 2002). Released infected cells 
could then drift away from original infection sites in the genital mucus and establish 
infection in new locations, which may help explain the phenomenon of chronic, 
ascending infection from the lower to the upper human genital tract.  
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Summary 
 
Studies from our laboratory indicate that during Chlamydia trachomatis/HSV co-
infection, the chlamydiae become persistent. Also, interaction of purified, recombinant 
HSV-2 glycoprotein D (gD) with the host cell surface mediates this effect in the absence 
of viral infection. Therefore, we hypothesize that gD/host cell surface receptor interaction 
initiates a host HeLa cell response that restricts chlamydial development. During viral 
entry, HSV gD interacts with one of 4 host co-receptors: HVEM (herpes virus entry 
mediator), nectin-1, nectin-2, and 3-O-sulfated heparan sulfate. HVEM and nectin-1 are 
high-affinity entry receptors for both HSV-1 and HSV-2. Nectin-2 mediates HSV-2 entry 
with high efficiency but is essentially inactive for HSV-1, while 3-O-sulfated heparan 
sulfate facilitates HSV-1, but not HSV-2, entry. Western blot and RT-PCR analyses 
demonstrate that HeLa and HEC-1B cells express nectin-1 and nectin-2, but no HVEM. 
Because both HSV-1 and HSV-2 trigger persistence, these data suggest that, of the co-
receptors, nectin-1 is the most likely involved. Interestingly, previously published studies 
indicate that nectin-1 is strongly down-regulated by 36 hours post-infection (h.p.i) in C. 
trachomatis-infected HeLa cells. Similarly, Western blot analyses demonstrate that 
nectin-1 is decreased by 68% in C. muridarum-infected HeLa cells by 24 h.p.i. Notably, 
HSV co-infection experiments using either C. muridarum or C. trachomatis indicate that 
the chlamydae become resistant to the effects of viral co-infection at 24 and 36 h.p.i, 
respectively. These data suggest that HSV co-infection can not interfere with chlamydial 
development in the absence of nectin-1. Co-infection experiments using nectin-1-specific 
HSV-1 mutants suggest that nectin-1 is, indeed, required for persistence induction. 
Additional studies in single co-receptor-expressing CHO cells demonstrate that, despite 
the fact that HSV-1 enters both HVEM and nectin-1-expressing cells, viral co-infection 
reduces chlamydial infectivity only in the CHO-nectin-1 cell line. These data confirm 
that virus/nectin-1 interaction is sufficient for chlamydial persistence induction. Although 
nectin-1 ligation is known to activate the small G protein, Cdc42, pull-down assays 
indicate that Cdc42 is not activated in co-infected HeLa cells. Thus, we hypothesize that 
this anti-chlamydial response is mediated through an as yet uncharacterized nectin-1-
activated host signaling pathway.  
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Introduction 
 
According to the Centers for Disease Control and Prevention, sexually transmitted 
diseases (STDs) are among the most common infections in the United States. 
Approximately 19 million new STDs cases occur each year in the United States, almost 
half of them among people ages 15 to 24 (Weinstock et al., 2004). Two of the most 
commonly reported STD agents in the United States are Chlamydia trachomatis (serovars 
D-K; 4,000,000 new cases/year) and Herpes Simplex Virus (primarily HSV-2; 200,000-
500,000 new cases/year) (Bulter, 1997).  
 
C. trachomatis is a Gram-negative, obligate intracellular bacterium that frequently 
causes chronic, asymptomatic genital infections. Such infections can result in 
complications such as epididymitis, prostatitis, ectopic pregnancy, salpingitis, and 
infertility (Darville, 2000a). All chlamydiae share a unique biphasic developmental cycle, 
alternating between two morphologically distinct forms. The extracellular,  infectious but 
metabolically inert form (the elementary body or EB, 0.3µm diameter) attaches to and 
enters mucosal epithelial cells via receptor mediated endocytosis (Wyrick, 2000). 
Following the fusion of EB-containing endosomes, EBs develop into larger (1µm 
diameter), metabolically active but non-infectious reticulate bodies (RBs). Using ATP 
and metabolites from the host cell, RBs grow and divide within an enlarged endosomal 
sac (the inclusion). After 8-12 rounds of replication, the RBs mature into infectious EBs, 
which are released from the host cell (Wyrick, 2000).  
 
When developing chlamydiae are exposed to unfavorable environmental 
conditions, they deviate from the normal developmental cycle into a viable but non-
infectious state termed persistence (Hogan et al., 2004), where they can remain for 
months (Galasso & Manire, 1961). Several studies have demonstrated that under 
appropriate circumstances, chlamydial persistence may occur in vivo (Bragina et al., 2001; 
Dean et al., 2000; Fortenberry et al., 1999; Gerard et al., 2001; Patton et al., 1994). 
Known inducers include IFN-γ, TNF-α and penicillin-exposure as well as amino acid, 
glucose and iron deprivation (Beatty et al., 1994a; Darville et al., 2000; Gerard et al., 
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2001; Raulston, 1997). Persistent chlamydiae continue to synthesize unprocessed 16S 
rRNA and replicate chromosomes but fail to divide (Gerard et al., 1998; Gerard et al., 
2001). At the ultrastructural level, persistent chlamydiae appear as swollen, misshapen, 
diffuse RBs with increased membrane blebbing. Notably, because they are viable, 
persistent chlamydiae have ability to re-enter and complete the normal developmental 
cycle once the persistence “inducer” is removed.  
 
Herpes simplex virus types 1 and 2 (HSV-1 and HSV-2) are members of the viral 
family Herpesviridae. The HSV virion has a large double-stranded DNA genome that is 
packed within a capsid shell, which is in turn coated with a protein layer (the tegument) 
and an envelope composed of lipids and more than a dozen viral glycoproteins (Spear & 
Longnecker, 2003). Though HSV-1 causes some genital infections, HSV-2 is the major 
causative agent of genital herpes. Initial HSV-2 infection usually occurs on the mucous 
membranes and skin surrounding the genitals, where painful skin vesicles are formed. 
The virus subsequently establishes life-long latent infection in the sacral ganglia. Viral 
replication and symptomatic infection can be periodically reactivated, during which 
lesions and virions are present (Corey et al., 1983).  
 
Entry of HSV into cells is initiated when the virion binds to cell surface receptor 
heparan sulfate using the viral envelope proteins gC and/or gB. The viral gD envelope 
glycoprotein then interacts with one of 4 cellular co-receptors, including HVEM (herpes 
virus entry mediator), nectin-1, nectin-2 or 3-O sulfated heparan sulfate (3-O-S-HS) 
(Spear, 2004). HVEM is a member of the tumor necrosis factor (TNF) receptor family 
which is present on lymphoid and epithelial cells and serves as a co-receptor for both 
HSV-1 and HSV-2. Nectin-1 and -2 are cell adhesion molecules belonging to the 
immunoglobulin superfamily which play important roles in the formation of adhesion and 
tight junctions (Sakisaka & Takai, 2004). Nectin-1 mediates entry of both HSV-1 and 
HSV-2 equally well, while nectin-2 facilitates HSV-2 entry but is nearly inactive for 
HSV-1. Conversely, 3-O-S-HS primarily mediates HSV-1 entry (Spear, 2004). The 
binding of gD to any one of the these co-receptors facilitates the fusion of the viral 
envelope with the host cell plasma membrane. Once the viral capsid enters the host cell, 
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replication takes place in the nucleus. New virions are assembled in the nucleus and 
egress the host cell by vesicular transport (Roizman, 2001a).  
 
Several previous studies from our laboratory demonstrate that HSV-2 super-
infection of C. trachomatis serovar E-infected genital epithelial cells induces chlamydial 
persistence (Deka et al., 2006). In addition, induction of C. trachomatis persistence by 
HSV is neither host cell type nor virus strain specific (Deka et al., 2007). De novo 
host/viral protein synthesis and productive HSV replication are not required for 
chlamydial persistence induction (Deka et al., 2007). Furthermore, HSV co-infection-
induced chlamydial persistence is not mediated by any previously identified persistence 
inducer or anti-chlamydial pathway (Vanover et al., 2008). Unpublished data (Vanover, 
2009b) from our laboratory indicate that HSV glycoprotein D (gD) interaction with host 
cell surface is sufficient to induce chlamydial persistence. Therefore, we performed co-
infections using co-receptor-specific HSV mutants and co-receptor expressing CHO host 
cell lines to test the hypothesis that virus interaction with one of the known co-receptors 
is sufficient to alter the chlamydial developmental cycle.  
 
Methods 
 
Cells, viruses and chlamydiae.  
Chinese hamster ovary (CHO) cell lines including CHO-C8 (containing the 
pcDNA3 plasmid vector alone), CHO-HVEM, CHO-nectin-1, and CHO-nectin-2 (kind 
gifts from Dr. Patricia Spear, Northwestern University) were used in co-infection 
experiments. CHO-C8 cells express cell surface HS but lack all known HSV co-receptors. 
HSV-1 KOS binds to CHO-C8 cells, but does not enter, even at multiplicities (10-100 
m.o.i) that infect HeLa cells with 100% efficiency (Johnson & Spear, 1989). CHO-
HVEM, CHO-nectin-1 and CHO-nectin-2 express recombinant HVEM, nectin-1 and 
nectin-2, respectively. CHO-HVEM and CHO-nectin-1 are permissive for HSV-1 KOS 
entry (Yoon & Spear, 2004). The other cell lines used in the study were HeLa cervical 
adenocarcinoma epithelial cells (ATCC No. CCL2) and HEC-1B endometrial epithelial 
cells (ATCC No. HTB-113). Wild type HSV strains HSV-2 333 and HSV-1 KOS were 
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obtained from Dr. Mary K. Howett (Drexel University) and Dr. Udayasankar 
Kumaraguru (East Tennessee State University), respectively. The parental stain HSV-1 
KOS/FRT-gD (expressing wild type gD) and the gD amino acid substitution mutants 
HSV-1 KOS/FRT-gDG43P, HSV-1 KOS/FRT-gDQ27P and HSV-1 KOS/FRT-gDA3C/Y38C 
were obtained from Dr. Patricia Spear (Northwestern University). The parental strain and 
all mutants express β-galactosidase (β-gal) activity upon host cell entry (Yoon & Spear, 
2004). C. trachomatis E/UW-5/CX was originally obtained from Dr. S.P.Wang and Dr. 
C.C.Kuo (University of Washington) and C. muridarum strain Nigg was obtained from 
Dr. Roger Rank (University of Arkansas Health Sciences Center).  
 
Co-infection experimental design.  
Co-infections were performed as previously described by Deka et al (Deka et al., 
2006). In most experiments, host cells were divided into four groups, 1x106 cells per 
60mm culture dish, for mock-infection, chlamydial-infection, HSV-infection, and 
chlamydia/HSV double infection. Host cells were infected with a dilution of crude EB 
stock (200 µl) calculated to infect > 80% of the cells and with HSV at an m.o.i of 10 (10 
PFU/cell). Mock-infected cells were treated similarly except they were exposed to 200 µl 
of either 2SPG (0.2 M sucrose, 6 mM NaH2PO4, 15 mM Na2HPO4, 5 mM L-glutamine, 
pH 7.2; mock chlamydial infection) or growth medium (mock viral infection).  
 
SDS-PAGE and Western blotting. 
Monolayers of host cells were lysed and denatured as previously described (Deka 
et al., 2006). The Western blot assays were conducted as described by Sun et al (Sun et 
al., 2008). Briefly, samples were quantified using SYPRO Ruby stain (Bio-Rad) 
according to the manufacturer’s instructions. Samples were diluted to identical 
concentrations, re-quantified to confirm that the relative concentrations were the same 
and subjected to SDS-PAGE and Western blotting (Deka et al., 2006). Primary 
antibodies used included mouse monoclonal anti-nectin-1 CK6 (1:200 dilution; sc-21722, 
Santa Cruz Biotechnology), goat polyclonal anti-chlamydial major outer-membrane 
protein (MOMP; 1:5000 dilution; B65266G, BioDesign International), mouse 
monoclonal anti-β-actin (1:5000 dilution; MAB1501, Chemicon), goat polyclonal anti-
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nectin-2 (1:1000 dilution; AF2229, R&D systems) and goat polyclonal anti-HVEM (N-
19) (1:500 dilution; sc-7766,  Santa Cruz Biotechnology). Primary antibody binding was 
detected with corresponding secondary antibodies conjugated to horseradish peroxidase 
and visualized using SuperSignal West Pico reagent (Pierce).  Bands of interest were 
quantified using an FX phosphorimager and Quantity One V2.5.0 software (Bio-Rad). To 
control for small variations in cell number and gel loading between sample lanes, the 
nectin-1 quantity in each sample was normalized to the amount of β-actin protein 
detected in that same lane (Sun & Schoborg, 2008).   
 
RNA isolation, reverse transcription and RT-PCR.  
Total RNA was isolated from experimental samples using the RNeasy Mini 
(Qiagen) kit as described previously (Deka et al., 2006). RNA preparations were 
quantified by measuring OD at 260 and 280 nm. All samples had OD260/OD280 ratios > 
1.9. Agilent bioanalyses also indicated that all RNAs used had a RIN of >9.8. RNA 
samples were subjected to reverse transcription as described previously (Deka et al., 2006) 
and RT-PCR reactions were subsequently carried out using RT(+) and RT(-) cDNA 
reactions as templates, as appropriate. Experimental template cDNAs were diluted from 
1/10 to 1/1000 in double-distilled H2O and synthetic control DNA targets were diluted 
from 10 to 0.01pg/ml, ensuring that each reaction was quantified in the linear 
amplification range. The specific primers and synthetic control DNA targets for HVEM 
and nectin-2 were designed using Vector NTI Advance V10 (Invitrogen) and are listed in 
Supplementary Table S1. Nectin-1α, -1β and -1γ specific primers and their 
oligonucleotide amplification controls were previously described (Sun et al., 2008). Most 
reactions were performed using the following cycling conditions (unless otherwise 
indicated): 94°C, 1 min; 60°C, 1 min; 72°C, 1 min for 35 cycles. The resulting PCR 
products were electrophoresed and quantified as previously described (Sun et al., 2008).  
 
β-galactosidase assay.  
This assay was performed as described previously (Montgomery et al., 1996). In 
this assay, β-gal expression (and virion entry) is indicated by the formation of an 
insoluble blue reaction product.  Six hours after HSV infection, cells were washed with 
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1x PBS and fixed with 2% formaldehyde/0.2% glutaraldehyde in PBS for 10 min at room 
temperature. Following fixation, the cells were washed with 1x PBS and permeablized 
with 2 mM MgCl2/0.01% deoxycholate/0.02% NP-40 in PBS for 10 min at room 
temperature. The cells were incubated with 0.5 mg/ml X-gal (5-bromo-3-indoyl-β-D- 
galactopyranoside) in PBS for at least 1 hour at 37°C. Images were obtained using an 
Epson Perfection 3200 Photo Scanner and Photoshop Elements Software.  
 
Chlamydial titration by subpassage.  
Chlamydial titrations were conducted as previously described (Deka et al., 2006) 
using Pathfinder anti-chlamydial stain (Bio-Rad) to stain chlamydial inclusions formed 
from subpassaged EBs. The number of inclusion-forming units (IFU) in the undiluted 
inoculum was derived from triplicate counts and expressed as IFU ml-1.  
 
Transmission electron microscopy.  
C. trachomatis-infected or C. trachomatis/HSV co-infected HeLa cells were 
processed for high-contrast TEM as described (Wyrick, 1994). Counter-stained gold thin 
sections were examined using a Tecnai 10 (FEI) transmission electron microscope 
operating at 60-80 kV. 
 
HSV-1 plaque assay.  
At 20h post HSV-1 infection, cell culture supernatants were collected and 
centrifuged at 4000g for 5 min at 4°C to remove cell debris. Plaque assays were 
performed on the resulting supernatants as described (Duff & Rapp, 1971). Quadruplicate, 
infected cultures were incubated with methylcellulose at 37°C for 72h, followed by 
removing methylcellulose and staining with a solution of 5% formaldehyde and 0.5% 
crystal violet for 1h. Plates were then washed and plaques were counted. Average plaque 
counts from each set of plates were used to calculate the pfu ml-1 present in the original 
supernatant.  
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Statistical analyses.  
Statistical analyses were performed using Microsoft Excel. A two-sample t test 
for independent samples was used for comparison of means; p-values ≤ 0.05 were 
considered significant.  
 
Results 
 
HeLa and HEC-1B cells express nectin-1 and nectin-2 but not HVEM. 
Previous data from our laboratory have demonstrated that HSV-induced 
chlamydial persistence occurs in both HeLa and HEC-1B cells (Deka et al., 2007). To aid 
in elucidating which, if any, host HSV co-receptors are involved, we first determined 
which co-receptors HeLa and HEC-1B cells express. HeLa or HEC-1B cell lysates were 
subjected to SDS-PAGE and Western blotted with either HVEM, nectin-1, nectin-2 or β-
actin antibodies. CHO-HVEM, CHO-nectin-1 and CHO-nectin-2 cell lysates were used 
as positive controls, respectively. As shown in Fig. 1(a), both HeLa and HEC-1B cells 
express nectin-1 and nectin-2, but not HVEM. As expected, HVEM, nectin-1 and nectin-
2 are easily detected in the appropriate CHO cell line. These data indicate that the HeLa 
and HEC-1B cell lines used in our experiments express nectin-1 and 2, but not HVEM. 
 
Because it is possible that HeLa and HEC-1B cells express only a small quantity 
of HVEM that was below the level of Western blot detection, total RNA from HeLa, 
HEC-1B, or CHO-HVEM cells was isolated and subjected to RT-PCR using specific 
primers for HVEM. In each experiment, a four log dilution series of synthetic control 
DNA was used to generate standard curves for amplification. Experimental samples were 
only quantified if they fell within the linear range of the PCR. All amplimers were the 
expected size (Fig. 1b) and the identity of each was confirmed by DNA sequencing (data 
not shown). Amplification products were not observed in template-negative samples (Fig. 
1b, lane 6) or in RT(-) controls (data not shown). As shown in Fig. 1(b), CHO-HVEM 
cell controls express a large amount of HVEM mRNA (lane 9). However, HVEM 
transcript was not observed in either HeLa or HEC-1B samples, even after 38 cycles of 
amplification (lanes 7 and 8). Similarly, total RNA from HeLa, HEC-1B and the 
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appropriate CHO control cell lines was subjected to RT-PCR using specific primers for 
nectin-1α, -1β, -1γ and nectin-2 (see supplementary data, Fig. S1a,b). As expected, both 
HeLa and HEC-1B cells express nectin-1 and nectin-2 mRNAs, although in a lower 
amount than do the CHO-nectin-1 or CHO-nectin-2 cell lines. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1 HeLa and HEC-1B cells express nectin-1 and nectin-2 but not HVEM. (a) 
HeLa or HEC-1B cell lysates were subjected to SDS-PAGE and Western blotted with 
either HVEM, nectin-1, nectin-2 or β-actin antibodies. CHO-HVEM, CHO-nectin-1 and 
CHO-nectin-2 cell lysates were used as positive controls, respectively. (b) Total RNA 
from HeLa, HEC-1B or CHO-HVEM cells was isolated and subjected to RT-PCR using 
specific primers for HVEM. In each experiment, a four log dilution series of synthetic 
control DNA was used to generate standard curves for amplification. Experimental 
samples were only quantified if they fell within the linear range of the PCR. The position 
of DNA size markers are shown to the left of each gel image in base pairs (bp).  
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Collectively, these above data demonstrate that both HeLa and HEC-1B cells 
express nectin-1 and nectin-2, but express little or no HVEM. In addition, it has been 
demonstrated that anti-HVEM antibodies only had marginal effects on the entry of HSV-
1 into HeLa cells, suggesting that HVEM is probably not a major receptor mediating 
HSV entry into HeLa cells (Montgomery et al., 1996). On the other hand, previous 
studies have demonstrated that both HSV-1 and HSV-2 trigger chlamydial persistence 
(Deka et al., 2007) and both use HVEM and nectin-1 equally well (Spear, 2004). 
Moreover, nectin-2 mediates HSV-2 entry with high efficiency but is nearly inactive for 
HSV-1, while 3-O-S-HS facilitates HSV-1, but not HSV-2 entry (Spear, 2004). Thus, 
together, these data suggest that, of the co-receptors, nectin-1 is the most likely candidate 
involved in HSV-induced chlamydial persistence.  
 
HSV co-infection does not affect the chlamydial developmental cycle in the absence of 
nectin-1. 
During the process of co-infection studies on C. trachomatis, we examined other 
chlamydial species to see whether they also enter persistence in HSV co-infected host 
cells. C. muridarum, formerly the mouse pneumonitis biovar of C. trachomatis, naturally 
infects only members of the family Muridae (Everett et al., 1999). HeLa cells were either 
mock-, HSV-2-, C. muridarum-, or co-infected. To determine the effect of HSV co-
infection on C. muridarum development, HeLa cells were infected with C. muridarum for 
6h, 12h or 24h, followed by HSV-2 infection. Cells were collected 20h post HSV-2 
infection and processed for chlamydial EB titration. As shown in Fig. 2(a), when 
compared with chlamydia singly-infected controls, production of infectious EBs was 
significantly decreased when HSV-2 was added at 6h and 12h post-chlamydial infection. 
In contrast, no significant reduction in chlamydial infectivity was observed when the 
virus was added at 24h post-chlamydal infection (Fig. 2a). In addition, the effect of HSV-
2 on C. muridarum infectivity is greater at 6h than at 12h.  
 
Published data from our laboratory demonstrated that nectin-1 is degraded in C. 
trachomatis-infected HeLa cells at 36 to 48 h.p.i (Sun et al., 2008). Based on this 
information, we examined C. muridarum-infected HeLa cells to see whether nectin-1 
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down-regulation correlates with the time post-infection at which C. muridarum becomes 
insensitive to HSV co-infection. HeLa cells were either mock- or C. muridarum-infected. 
Cell lysates were collected at 0, 6, 12, 24, 36 h.p.i and Western blotted with (i) anti-
nectin-1, (ii) anti-MOMP, (iii) anti-β-actin. A representative blot is shown in Fig. 2(b); 
the quantification of nectin-1 is shown in Fig. 2(c).  These data clearly demonstrate that C. 
muridarum also degrades nectin-1 and that significant degradation is first observed at 24 
h.p.i. Thus, these results suggest that HSV co-infection can not disrupt the normal 
chlamydial developmental cycle in the absence of nectin-1.  
 
It is important to note that, in all of our published co-infection experiments using 
C. trachomatis, the virus was added at 24 h post-chlamydia infection. Our data indicate 
that in C. trachomatis-infected HeLa cultures nectin-1 quantity is essentially unaltered at 
24 h.p.i (Sun et al., 2008). Therefore, we also examined whether HSV co-infection can 
influence chlamydial development when HSV was added at 36h and 48h post C. 
trachomatis-infection, at which times significant nectin-1 down-regulation is observed 
(Sun et al., 2008). HeLa cells were either mock-, HSV-2-, C. trachomatis-, or co-infected. 
For co-infected HeLa cells, cells were co-infected with HSV-2 either 24h, 36h, or 48h 
after addition of the chlamydiae. Cells were collected at 20h post HSV-2 infection and 
processed for chlamydial EB titration. As shown in Fig. 2(d), when compared with 
chlamydia singly-infected controls, a significant decrease in the production of infectious 
EBs occurred in co-infected cells when HSV-2 was added at 24h and 36h but not when 
HSV-2 was added at 48h post-chlamydial infection. In addition, the effect of HSV-2 on C. 
trachomatis infectivity is greater at 24h than at 36h. These data are consistent with the C. 
muridarum results and suggest that nectin-1 is required for HSV co-infection-induced 
disruption of the chlamydial developmental cycle.  
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Figure 4.2 HSV co-infection does not affect the chlamydial developmental cycle in the 
absence of nectin-1. (a) HeLa cells were either mock-, HSV-2-, C. muridarum-, or co-
infected. For co-infected HeLa cells, cells were infected with C. muridarum for 6h, 12h 
or 24h, followed by HSV-2 infection. Cells were collected 20h post HSV-2 infection and 
processed for chlamydial EB titration. Asterisks (*) indicate titres that are significantly 
different compared with those from C. muridarum singly-infected cells (P<0.05). (b) 
HeLa cells were either mock- or C. muridarum-infected. Cell lysates were collected at 0, 
6, 12, 24, 36 h.p.i and Western blotted with (i) anti-nectin-1, (ii) anti-MOMP, (iii) anti-β-
actin. (c) The quantity of nectin-1 detected in panel (b) was normalized to the internal 
control protein β-actin and plotted. Groups significantly (P<0.05) different from C. 
trachomatis-infected cells at 0 h.p.i are indicated by asterisks (*). (d) HeLa cells were 
either mock-, HSV-2-, C. trachomatis-, or co-infected. For co-infected HeLa cells, cells 
were co-infected with HSV-2 either 24h, 36h or 48h after addition of the chlamydiae. 
Cells were collected at 20h post HSV-2 infection and processed for chlamydial EB 
titration. Asterisks (*) indicate titres that are significantly different compared with those 
from C. trachomatis singly-infected cells (P<0.05). The data shown in this figure are 
representative of three independent experiments. 
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HSV-induced chlamydial persistence requires nectin-1. 
Our published and unpublished data suggest that HSV gD/co-receptor interaction 
halts the chlamydial developmental cycle. As a further step in defining if nectin-1 is 
involved, we have examined if HSV-induced chlamydial persistence requires nectin-1 by 
co-infection using HSV-1 mutants with altered co-receptor specificities. HeLa cells were 
either mock-, singly-, or co-infected with C. trachomatis and various wild type (HSV-2 
and HSV-1 KOS/FRT-gDwt) or mutant viruses (HSV-1 KOS/FRT-gDG43P, HSV-1 
KOS/FRT-gDQ27P, and HSV-1 KOS/FRT-gDA3C/Y38C). HSV-2 (333) co-infection was 
used as a positive control for chlamydial persistence induction. The parental stain HSV-1 
KOS/FRT-gD expresses wild type gD and enters host cells via HVEM, nectin-1, and 3-
O-S-HS with high/moderate efficiency and via nectin-2 with very low efficiency. HSV-1 
KOS/FRT-gDG43P can only enter using nectin-1. HSV-1 KOS/FRT-gDQ27P uses both 
nectin-1 and nectin-2 equally well. Neither G43P nor Q27P use HVEM or 3-O-S-HS, 
even when infections are performed at an m.o.i of 200 (Yoon & Spear, 2004). HSV-1 
KOS/FRT-gDA3C/Y38C uses HVEM and 3-O-S-HS but not the nectins to enter host cells. 
The parental stain and the three mutants also express β-gal activity upon host cell entry 
(Yoon & Spear, 2004). Cells were collected at 20h post viral infection and processed for 
chlamydial EB titration as described in the Methods. As shown in Fig. 3(a), HSV-2, gDwt 
and all three mutants significantly reduced chlamydial EB production. Because we have 
found HeLa cells express little or no HVEM and HSV-1 KOS/FRT-gDA3C/Y38C has been 
reported to be HVEM/3-O-S-HS specific (Yoon & Spear, 2004), it was unexpected to see 
the double mutant represses chlamydial infectivity.  
 
To find out the reason behind this phenomenon, we performed β-gal assays to 
check the specific entry phenotypes of HSV-1 KOS/FRT-gDwt, -gDG43P, -gDQ27P, and -
gDA3C/Y38C using CHO cell lines expressing single co-receptors: CHO-C8, CHO-HVEM, 
CHO-nectin-1, and CHO-nectin-2. CHO-C8 cells express cell surface HS but lack any 
known HSV co-receptors. As shown in Fig 3(b), as expected, no β-gal activity is 
observed in CHO-C8 cells. For gDwt-infected cells, β-gal activity is strongly expressed in 
CHO-HVEM and CHO-nectin-1 but is weakly expressed in CHO-nectin-2. These results 
were expected because nectin-2 supports HSV-2 entry but is nearly inactive for entry of 
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HSV-1. For gDG43P-infected cells, β-gal activity is only present in the CHO-nectin-1 well. 
HSV-1 KOS-gDQ27P expresses β-gal activity in both CHO-nectin-1 and CHO-nectin-2 
cells, as expected. In gDA3C/Y38C-infected cells, β-gal activity is present in CHO-HVEM 
cells. However, we also observed a low, but reproducible, level of β-gal expression in 
CHO-nectin-1 cells, which indicates that despite the published reports (Yoon & Spear, 
2004), gDA3C/Y38C can attach to and enter nectin-1 expressing CHO cells, albeit at an 
efficiency much lower than that observed for HVEM-expressing cells. Given that the 
only co-receptor usage that the three mutants share is nectin-1, these data suggest that 
virus interaction with this co-receptor is necessary for persistence induction in our system. 
 
We also tested the specific entry phenotypes of HSV-1 KOS/FRT-gDwt, -gDG43P, -
gDQ27P, and -gDA3C/Y38C on HeLa cells. As shown in Fig. 3(c), no β-gal activity is present 
in mock-, C. trachomatis-, HSV-2- or C. trachomatis /HSV-2-infected HeLa cells. As 
expected, the wild type (gDwt) and the two mutants (gDG43P and gDQ27P) enter HeLa cells 
with high efficiency. However, the double mutant gDA3C/Y38C does not show detectable 
entry activity in this assay, which is not surprising since this assay is relatively insensitive 
and nectin-1 expression on HeLa cells is much lower than that on CHO-nectin-1 cells, as 
shown by the data in Fig. 1(a) (middle panel).  
 
Persistent forms of C. trachomatis have a characteristic electron microscopic 
appearance (Beatty et al., 1993; Matsumoto & Manire, 1970). To confirm the results 
from Fig. 3(a), we therefore conducted transmission electron microscopy as described in 
the Methods. Electron micrographs demonstrated that in C. trachomatis singly-infected 
HeLa cells, EBs were present and RBs appeared normal (Fig. 3d). In contrast, in HSV-1 
KOS/FRT-gDwt, -gDG43P, -gDQ27P, or -gDA3C/Y38C co-infected HeLa cells, EBs were 
absent from chlamydial inclusions and the RB exhibited an enlarged, abnormal 
morphology as well as increased membrane blebs, characteristic of persistence (Fig. 3d). 
Collectively, these data are again consistent with the supposition that nectin-1 is required 
for HSV co-infection-induced chlamydial persistence.  
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Figure 4.3 HSV-induced chlamydial persistence requires nectin-1. (a) HeLa cells were 
either mock-, singly-, or co-infected with C. trachomatis and various wild type (HSV-2 
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and HSV-1 KOS/FRT-gDwt) or mutant viruses (HSV-1 KOS/FRT-gDG43P, HSV-1 
KOS/FRT-gDQ27P and HSV-1 KOS/FRT-gDA3C/Y38C). HSV-2 co-infection was used as a 
positive control for chlamydial persistence induction. Asterisks (*) indicate titres that are 
significantly different compared with those from C. trachomatis singly-infected cells 
(P<0.05). (b) CHO cell lines expressing single co-receptors, CHO-C8, CHO-HVEM, 
CHO-nectin-1 and CHO-nectin-2, were infected with HSV-1 KOS/FRT-gDwt, -gDG43P, -
gDQ27P and -gDA3C/Y38C, respectively, for 6 hours. The infected cells were then processed 
by β-gal assays as described in the Methods. (c) HeLa cells were either mock-, singly-, or 
co-infected with C. trachomatis and HSV-2, HSV-1 KOS/FRT-gDwt, -gDG43P, -gDQ27P or 
-gDA3C/Y38C, respectively, for 6 hours. The infected cells were then processed by β-gal 
assays as described in the Methods. (d) HeLa cells were either mock-, C. trachomatis-
infected or co-infected with C. trachomatis and HSV-2, HSV-1 KOS/FRT-gDwt, -gDG43P, 
-gDQ27P or -gDA3C/Y38C, respectively. Cells were harvested for TEM analyses. White 
arrows on electron micrographs indicate EBs; Red arrow indicates normal RB; black 
arrows indicate abnormal RBs. The data shown are representative of three independent 
experiments.  
 
 
 
 
HSV attachment/entry using nectin-1 alone is sufficient to induce chlamydial persistence. 
Previous studies indicate that HSV attachment and/or entry into the host cells is 
sufficient for inducing chlamydial persistence (Deka et al., 2007), suggesting that viral 
attachment/entry may provide the necessary stimulus to trigger a novel host pathway 
which restricts chlamydial development (Vanover et al., 2008). To confirm that nectin-1 
is, indeed, required for this process, we performed co-infections with C. trachomatis and 
HSV-1 KOS in the previously described single co-receptor expressing CHO cell lines. 
Cells were first chlamydia infected, and then HSV-1 KOS was added 24 hours later. Cells 
were collected at 20h post HSV-1 infection and processed for chlamydial EB titration and 
plaque assays. Chlamydial titer analyses demonstrated that though there are differences in 
total C. trachomatis production from different CHO cell lines, the characteristic HSV-1-
induced reduction in chlamydial infectivity is only observed in the positive control co-
infected HeLa cells and in co-infected CHO-nectin-1 cells (Fig. 4). As expected, 
supernatant plaque assays demonstrate that co-infected CHO-HVEM and CHO-nectin-1 
cells produce similar amounts of virus, while CHO-C8 cultures produce essentially none 
(data not shown). These data are consistent with our previous observation that HSV-1 
enters CHO-HVEM and CHO-nectin-1 cells with high efficiency while showing no 
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detectable entry activity in CHO-C8 cells (Fig. 3b). Therefore, these data confirm that 
HSV-attachment/entry using nectin-1 co-receptor alone is sufficient to induce chlamydial 
persistence. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.4 HSV attachment/entry using nectin-1 alone is sufficient to induce chlamydial 
persistence. HeLa, CHO-C8, CHO-HVEM, CHO-nectin-1 and CHO-nectin-2 were either 
C. trachomatis-infected or co-infected with C. trachomatis and HSV-1 KOS. For co-
infected cells, Cells were first chlamydia infected, and then HSV-1 KOS was added 24 
hours later. Cells were collected at 20h post HSV-1 infection and processed for 
chlamydial EB titration. Asterisk (*) indicates titre that is significantly different 
compared with that from C. trachomatis singly-infected same cells (P<0.05). The data 
shown are representative of three independent experiments.  
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Discussion 
 
When exposed to certain adverse environmental factors, developing chlamydiae 
deviate from the normal developmental cycle into a viable but non-replicative persistent 
state (Hogan et al., 2004) and can remain in this state for weeks or months (Galasso & 
Manire, 1961). Persistent chlamydial infections increase the likelihood that an individual 
will experience prolonged inflammation of the genital tract and, thus, increasing the 
possibilities for development of severe disease sequelae. Several inducers of chlamydial 
persistence have been well studied, including interferon-γ (IFN-γ), IFN-α, IFN-β, tumor 
necrosis factor-α (TNF-α), and penicillin G exposure, as well as amino acid, iron, and 
glucose deprivation (Beatty et al., 1994a; Darville, 2000b; Gerard et al., 2001; Raulston, 
1997). Previously, our laboratory has established a tissue culture model of C. 
trachomatis/HSV-2 co-infection system. Data from this model indicate that viral co-
infection stimulates chlamydiae to become persistent (Deka et al., 2006), as evidenced by 
numerous observations: i) fewer or no EBs and enlarged, abnormal RB morphology; ii) a 
significant decrease in infectious chlamydial EB production; iii) decreased accumulation 
of chlamydial major outer membrane protein (MOMP) and increased accumulation of 
chlamydial heat-shock protein HSP-1 (HSP60-1); iv) continued accumulation of 
chlamydial genomic DNA and constant expression of chlamydial 16S rRNA transcripts.  
 
Subsequently, Deka et al have demonstrated that viral co-infection-induced 
chlamydial persistence is not host cell type-specific because it occurs in both HeLa and 
HEC-1B cell lines (Deka et al., 2007). HSV induction of chlamydial persistence is also 
not virus-specific due to both HSV-1 and HSV-2 co-infection can interfere with normal 
chlamydial development (Deka et al., 2007). Additionally, our laboratory has 
demonstrated that co-infection-stimulated chlamydial persistence is not mediated by any 
currently characterized persistence inducer or anti-chlamydial pathway (Vanover et al., 
2008), suggesting a novel host pathway may be triggered by viral co-infection to restrict 
chlamydial development. Furthermore, co-infection with UV-inactivated, replication-
incompetent virus or replication-competent HSV-2 in the presence of cyclohexamide 
drives chlamydiae to become persistent, indicating productive viral replication is not 
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required for this effect and suggesting that events during HSV attachment/entry are 
sufficient to stimulate co-infection-induced persistence (Deka et al., 2007). Finally, 
unpublished data from our laboratory demonstrate that exposure of C. trachomatis-
infected cells to cross-linked, soluble HSV envelope glycoprotein D:Fc fusion proteins 
decreases chlamydial infectivity, indicating that interaction of HSV gD with the host cell 
surface is sufficient to stimulate chlamydial persistence (Vanover, 2009a).  
 
HSV gD is the main determinant of cell recognition for viral entry. During the 
initial stages of viral invasion, gD binds to one of its co-receptors: nectin-1, nectin-2, 3-
O-S-HS, and HVEM, followed by fusion of viral envelope and host cell membrane. 
Nectin-1 and nectin-2 are important cell adhesion molecules of the immunoglobulin 
super-family and are distributed on fibroblasts and epithelial cells. They mainly are 
involved in formation and maintenance of adherens and tight junctions (Sakisaka & Takai, 
2004). While nectin-1 mediates entry of both HSV-1 and HSV-2, nectin-2 mediates entry 
of primarily HSV-2 (Spear, 2004). 3-O-S-HS is widely expressed on human cells and 
facilitates HSV-1, but not HSV-2, entry (Spear, 2004). HVEM is a member of the TNF 
receptor family. Its natural ligands include LIGHT, B and T lymphocyte attenuator 
(BTLA) and lymphotoxin-α (Gonzalez et al., 2005; Sedy et al., 2005). HVEM is present 
on lymphoid and epithelial cells and serves as a high-affinity entry co-receptor for both 
HSV-1 and HSV-2 (Spear, 2004). However, Montgomery et al. have shown that HVEM 
is probably not the primary receptor for HSV entry into HeLa cells, even HVEM cDNA 
was originally cloned from a HeLa cell library, because anti-HVEM serum only had 
marginal effects on the entry of HSV-1 into HeLa cells (Montgomery et al., 1996). On 
the other hand, unpublished data by Vanover et al. from our laboratory have shown that 
non-crosslinked soluble HSV-2 gD:Fc fusion proteins interaction with HeLa cells did not 
stimulate chlamydial persistence. However, when chlamydiae-infected HeLa cells 
exposed to immunoglobulin cross-linked gD:Fc fusion proteins, the developing 
chlamydiae became persistent (Vanover, 2009a). Interestingly, the dimerizing of nectins 
is required for nectin trans-interaction induced downstream cell signaling cascades (Ogita 
& Takai, 2006b). Finally, our studies have shown that both HSV-1 and HSV-2 can drive 
developing chlamydiae to enter persistence state (Deka et al., 2007). Thus, collectively, 
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these observations suggest that, of the four known co-receptors, nectin-1 is the most 
potential candidate for stimulating HSV co-infection-induced chlamydial persistence in 
this system.  
 
In the present study, the goal was to test the hypothesis that nectin-1 is required 
for HSV co-infection-induced chlamydial persistence. We first examined which HSV co-
receptors were expressed in HeLa and HEC-1B cells based on the fact that HSV co-
infection-induced persistence occurs in both HeLa and HEC-1B cells (Deka et al., 2007). 
Notably, both Western blot and RT-PCR analyses demonstrate that HeLa and HEC-1B 
cells express nectin-1 and nectin-2, but not HVEM. These observations are consistent 
with the supposition that nectin-1 is the most likely candidate for stimulation of co-
infection-induced persistence. Secondly, co-infection studies in C. muridarum revealed 
that a significant decrease in chlamydial infectivity occurs in co-infected cells when 
HSV-2 is added at 6h and 12h but not at 24h post-chlamydial infection. The effect caused 
by HSV-2 on C. muridarum infectivity is greater at 6h than at 12h. Additional studies 
demonstrate that there is a nearly 68% reduction in host cellular nectin-1 by 24 hours 
post-C. muridarum infection. These data suggest that HSV co-infection does not interfere 
with chlamydial development in the absence of nectin-1, which supports the hypothesis 
that nectin-1 interaction with HSV is probably required for stimulating a novel host 
pathway to induce chlamydial persistence. Thirdly, using HSV-1 mutants with altered co-
receptor specificities, we examined whether HSV co-infection-induced chlamydial 
persistence requires nectin-1 by chlamydial titration assay and TEM. Surprisingly, we 
found that co-infection in HeLa cells with the parental strain HSV-1 KOS/FRT-gDwt or 
the three HSV-1 mutants HSV-1 KOS/FRT -gDG43P, -gDQ27P, and -gDA3C/Y38C drove the 
chlamydiae to become persistent. These results were unexpected because HeLa cells do 
not express HVEM (Fig. 1a) and -gDA3C/Y38C is only HVEM/3-O-S-HS specific (Yoon & 
Spear, 2004). However, we observed later by β-gal assays that despite the reported results 
that gDA3C/Y38C enters cells via HVEM and 3-O-S-HS (Yoon & Spear, 2004), gDA3C/Y38C 
has lower ability to attach to and enter nectin-1-expressing CHO cells. Therefore, the 
only co-receptor usage that the parental strain and the three mutants share is nectin-1. 
Because β-gal assay is relatively insensitive and nectin-1 expression on HeLa cells is 
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much lower than that on CHO-nectin-1 cells (Fig. 1a), it is not surprising to see no 
detectable β-gal activity of gDA3C/Y38C in HeLa cells. Finally, we determined whether 
HSV attachment/entry using nectin-1 co-receptor alone is sufficient to stimulate 
chlamyidal persistence using co-receptor-deficient CHO cell lines. The results 
demonstrated that HSV-1-induced reduction in chlamydial infectivity is only observed in 
positive control HeLa co-infection and in CHO-nectin-1 cells, but not in CHO-C8, CHO-
HVEM, and CHO-nectin-2 cells. Although Western blotting and RT-PCR analyses 
demonstrated that HeLa cells and HEC-1B cells do not express HVEM, it is possible that 
the expression of HVEM is below our detection level. However, the fact that CHO-
nectin-1 cells support persistence during co-infection while CHO-HVEM cells do not 
provides very strong evidence that HSV interaction with nectin-1 triggers viral co-
infection-induced persistence. It is especially important to point out that HSV-1 enters 
and produces progeny virions in both CHO-nectin-1 and CHO-HVEM cells, but 
chlamydial infectivity is decreased only when nectin-1 is present. These data suggest that 
co-infection induced persistence specifically results from HSV gD/nectin-1 interaction 
with nectin-1, rather than from events that occur during or subsequent to virion entry. 
Overall, these observations confirmed that nectin-1 is indeed required for HSV co-
infection-induced chlamydial persistence.  
 
As mentioned before, HSV co-infection-induced chlamydial persistence is not 
mediated by any known persistence inducer or anti-chlamydial pathway (Vanover et al., 
2008), suggesting a novel host signaling pathway activated by interaction of HSV gD 
with nectin-1 could have a negative effect on chlamydial development. Studies have 
shown that the trans-interactions of nectins induce activation of cellular signaling 
molecule Cdc42 small G proteins through c-Src. The activation of Cdc42 and c-Src 
furthermore cause the activation of Rac small G proteins. Activated Cdc42 and Rac 
selectively induce activation of c-Jun N-terminal kinase, but not p38 MAP kinase or 
extracellular signal-regulated kinase (ERK) (Takai et al., 2003). Eventually, activated 
Cdc42 and Rac are involved in regulation of cell-cell adhesion, gene expression and cell 
polarization (Takai et al., 2003). Interestingly, temporarily activated Cdc42 and Rac1 
have been observed at 15 and 30 min after HSV-1 infection of MDCK canine kidney 
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cells (Hoppe et al., 2006). It is very intriguing to envision that HSV/nectin-1 interaction-
activated chlamydial persistence response is transmitted through the Cdc42/Rac1 
signaling pathway. However, active GTPase pull-down assays indicate that Cdc42 is not 
activated in co-infected HeLa cells (see supplementary data, Fig. S4.2), suggesting this 
anti-chlamydial response is likely mediated through another, as yet uncharacterized, 
nectin-1-activated host signaling pathway. Identification of this uncovered nectin-1-
activated cellular signal transduction pathway will be conducted in future in that 
dissection of this pathway will increase our understanding of the host immune response 
to chlamydial infection and provide new and valuable information of chlamydia/host cell 
interaction.  
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Supplementary Material 
 
 
 
 
 
 
 
 
 
 
 
 
Supplementary Figure 4.1 (a) and (b) HeLa and HEC-1B cells express nectin-1 and 
nectin-2. Total RNA from HeLa, HEC-1B and the appropriate CHO control cell lines was 
isolated and subjected to RT-PCR using specific primers for nectin-1α, -1β, -1γ and 
nectin-2. In each experiment, a four log dilution series of synthetic control DNA was 
used to generate standard curves for amplification. Experimental samples were only 
quantified if they fell within the linear range of the PCR. The position of DNA size 
markers are shown to the left of each gel image in base pairs (bp).  
 
 
 
 
 
 
 
 
 
 
 
Supplementary Figure 4.2 Endogenous Cdc42 activities upon HSV-1 infection. HeLa 
cells at low density were infected with HSV-1.  The levels of GTP-bound Cdc42 were 
determined in uninfected cells (mock) and in cells at 15, 30, 60, 120 min post-infection. 
Pull-down experiments were performed according to the manufacturer’s instructions 
(#89857, Active Cdc42 Pull-Down and Detection Kit, Thermo Scientific). Equal amounts 
of samples were resolved on SDS-PAGE gels and subjected to Western blotting using 
mouse anti-Cdc42 antibodies. In vitro GTPγS and GDP control treatments were 
performed to ensure the pull-down procedures were working properly.  
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Supplementary Table S4.1. RT-PCR primers and positive control oligonucleotides.  
Name Forward primer Reverse primer 
Nectin-2 TCGGAGCACAGCCCACTCAA TTGTGGCTCCAGGGTGCA 
HVEM TGTGTGAACCCTGCCCTCCA GCGTTCTCTGTCCTGGAGCA 
Nectin-2 positive 
control 
oligonucleotide 
CCTCGGAGCACAGCCCACTCAAGACCCCCTACTTTGATGCTGGCGC
CTCATGCACTGAGCAGGAAATGCCTCGATACCATGAGCTGCCCACC
TTGGAAGAACGGTCAGGACCCTTGCACCCTGGAGCCACAAGCCTGG
GG 
 
HVEM positive 
control 
oligonucleotide 
CACAGTGTGTGAACCCTGCCCTCCAGGCACCTACATTGCCCACCTC
AATGGCCTAAGCAAGTGTCTGCAGTGCCAAATGTGTGACCCAGCCA
TGGGCCTGCGCGCGAGCCGGAACTGCTCCAGGACAGAGAACGCCGT
GT 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 109
CHAPTER 5 
 
CONCLUSIONS 
 
Over the years, extensive research efforts have been put into uncovering the 
pathogenic mechanisms by which C. trachomatis causes disease. Numerous 
investigations have revealed that C. trachomatis has evolved a variety of strategies to be 
able to productively replicate and persistently survive within the eukaryotic host cell. For 
example, upon infection, C. trachomatis prevents infected cells from undergoing 
apoptosis, which allows the chlamydiae to maintain long-term infection within host cells. 
C. trachomatis can also alter host cell-cell contacts and signal transduction pathways, 
facilitating chlamydial growth. Finally, C. trachomatis also modifies the host cell 
cytoskeleton, benefiting chlamydial intravacuolar replication.  
 
In our study, we first showed that nectin-1, an important component of host cell 
adhesion junctions, is significantly decreased in C. trachomatis-infected genital epithelial 
cells (Sun et al., 2008). We further demonstrated that CPAF, a chlamydia-secreted 
protease, is responsible for nectin-1 degradation (Sun, 2009). Recently, several 
investigators have reported data that suggest that CPAF has important roles in chlamydial 
replication, growth, and dissemination. Zhong et al. reported that CPAF cleaves RFX5, 
USF-1, pro-apoptotic BH-3 only proteins and keratin-8. RFX5 and USF-1 are 
transcription factors, which are required for MHC class I and II antigen expression 
(Zhong et al., 1999; Zhong et al., 2000). Cleaving RFX5 and USF-1 as well as subquent 
suppressing MHC class I and II antigen expression may help infected cells escape 
immune detection. Therefore, the chlamydiae would have sufficient time to complete 
their replication in infected hosts. Pro-apoptotic BH-3 only proteins are required for 
apoptosis in response to cytotoxic stimuli or exogenous stress, and they function by 
neutralizing their pro-survival counterparts or activating pro-apoptotic Bcl-2 family 
members Bax and Bak (Pirbhai et al., 2006). Down-regulation of BH-3 only proteins 
contributes to chlamydial anti-apoptotic activity which may help chlamydiae evade CTL-
mediated host cell apoptosis induction and, thus, benefit chlamyidal long-term survival 
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within infected host cells (Pirbhai et al., 2006). Keratin-8 is a component of intermediate 
filaments and is also a major plasminogen receptor in select epithelial and carcinoma 
cells (Dong et al., 2004c). Cleavage of keratin-8 would increase the solubility of the host 
cell cytoskeleton, thus facilitating the expansion of chlamydia-laden inclusion, which is 
essential for chlamydial intracellular replication. Kawana et al. also found that CPAF can 
effectively degrade CD1d glycoprotein, an MHC-like protein that presents lipid antigen 
to natural killer T cells (Kawana et al., 2007). Degradation of CD1d protein may prevent 
recognition or elimination of chlamydiae from the host innate immune system (Kawana 
et al., 2007). Balsara et al. demonstrated that CPAF activity induces proteolysis of 
mitotic cyclin B1, a protein involved in cell cycle, resulting in a slowed progression of 
infected cells through the later stages of the cell cycle (Balsara et al., 2006). 
Unfortunately, the lack of a genetic system in chlamydiae has made it difficult to directly 
determine whether CPAF function is necessary for chlamydial development or disease. 
However, several indirect observations suggest that CPAF is, indeed, vitally important 
for development and/or establishment of infection. First, all chlamydial genomes yet 
sequenced contain a CPAF homologue (Read et al., 2000; Read et al., 2003; Stephens et 
al., 1998). It seems unlikely that the gene would be evolutionarily maintained if it were 
not required for progression of the developmental cycle or successful infection by the 
organism. Second, immunization of naive mice with purified CPAF protein induces an 
immune response that protects against subsequent vaginal challenge with C. muridarum 
(Li et al., 2007; Li et al., 2008), indirectly indicating that CPAF is likely to be important 
for maintenance of infection in vivo. Given these data, CPAF likely has critical roles in 
both protecting infected cells from host immune detection and facilitating chlamydial 
intracellular growth and survival. Thus, it appears that chlamydiae have evolved a single 
molecule (CPAF) for multiple purposes.  
 
What are the possible biological consequences of nectin-1 degradation? As 
mentioned before, nectin-1 is an adhesion molecule that is critically important for the 
formation and maintenance of AJs and TJs. As a result, we would predict that 
degradation of nectin-1 would inevitably affect the integrity of host cell-cell junctions. 
This notion is supported by recent data showing that cervical epithelial cells separate 
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from each other as a consequence of C. trachomatis infection (Prozialeck et al., 2002). 
Numerous studies have shown that some important human pathogens, such as 
Helicobacter pylori, Shigella flexneri and Salmonella typhimurium, down-regulate 
essential components of adhesion and tight junctions including E-cadherin, claudin-1, and 
ZO-1. This down-regulation leads to decreased transepithelial electrical resistance and 
increased paracellular permeability, which facilitates cell-to-cell spreading of these 
pathogens (Jepson et al., 1995; Sakaguchi et al., 2002; Sears, 2000; Terres et al., 1998). 
These findings suggest that disruption of adhesion and tight junctions to compromise 
cell-cell barriers may be an important strategy exploited by intracellular pathogens to 
ensure their dissemination. Although C. trachomatis serovar E is not an invasive 
pathogen, it may diminish nectin-1 expression and subsequently disrupt cell-cell 
adhesions, aiding lateral cell-to-cell spread. Alternatively, nectin-1 down-regulation 
might facilitate host structural rearrangements required for inclusion enlargement or EB 
release at the end of the developmental cycle. This prediction is supported by the 
observation that nectin-1 accumulation starts to decrease at 36 hpi, which is mid-
developmental cycle for C. trachomatis serovar E (Sun et al., 2008).  
 
Another intriguing possibility is that CPAF-mediated down-regulation of nectin-1 
might facilitate long distance C. trachomatis dissemination within the host genital tract 
(Fig. S2.3). Weakening of contacts by CPAF between an infected host genital epithelial 
cell and adjacent, uninfected cells could allow release of the intact, infected cell into 
genital tract lumen. The infected cell would then drift away via fluid dynamics or tissue 
movement from the original infection site to a new tissue site, aiding establishment of 
ascending genital tract infection. Notably, release of intact, chlamydiae-infected host 
cells from polarized monolayers in culture (Wyrick et al., 1989) as well as from infected 
epithelium in vivo has been observed (Doughri et al., 1972; Rank et al., 2008; Soloff et 
al., 1985). Soloff et al. (Soloff et al., 1985) and Doughri et al. (Doughri et al., 1972) 
observed that PMNs are in direct contact with epithelial cells in guinea-pig cervical cells 
infected with C. caviae and bovine intestinal epithelial cells infected with C. psittaci, 
respectively. Recently, Rank et al. (Rank et al., 2008) have observed a similar 
phenomenon in in vivo using a guinea-pig conjunctival model of C. caviae infection. 
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They also presented ultrastructural evidence that, in contrast to lysis of infected cells, the 
majority of infected cells are pushed off the epithelium. Most of the detached, infected 
cells appear to be healthy with intact microvilli, nuclei, and mitochondria. Rank et al. 
further proposed that PMNs responding to chlamydial infection participated in the 
detachment of chlamydia-infected cells from the mucosal surface, resulting in the release 
of intact, infected cells. As PMN infiltration intensifies, they also observed breaches in 
the epithelial monolayer, resulted from weakened and disrupted epithelial tight junctions, 
desmosomes and junctional complexes. These data are consistent with our observation 
that nectin-1 is degraded by CPAF in C. trachomatis-infected genital epithelial cells. 
Thus, it appears reasonable to hypothesize that the PMNs literally push intact, infected 
cells out of the mucosal epithelial layer. Given our data, we would assert that the 
chlamydia-mediated down-regulation of nectin-1 facilitates this process by loosening the 
junctions between adjacent host epithelial cells (Fig. 5.1). If nectin-1 degradation does 
indeed facilitate release of intact, infected cells from the genial mucosa, the question 
remains - how might this process benefit the chlamydiae? We would propose that release 
of infected cells provides at least two beneficial functions. First, the detached infected 
cells provide a protected niche for chlamydial EBs from neutralization by secretory IgA, 
cationic anti-microbial peptides and other anti-bacterial compounds in surrounding 
environment. Second, the inflammatory reaction is very intense at the local site of 
original infection because of increased local production of IFN-gamma and other anti-
chlamydial cytokines; it is therefore likely that few susceptible cells would be available. 
The dislodging of infected cells may allow the chlamydial EBs to be delivered to new, 
uninfected tissue sites in the genital tract. Once the infected cells ruptured, the local 
concentration of infectious EB would be very high, increasing the possibility that 
mucosal epithelia would be successfully infected. In contrast, EBs liberated from host 
cells still within the genital epithelial layer would be both quickly diluted and 
immediately subject to neutralization by anti-bacterial compounds. An in vitro time-lapse 
cinematographic study by Neeper et al showed the dramatic bursting of an infected cell to 
release EBs into the surrounding milieu (Neeper et al., 1990). Thus, based on the 
available information, we envision that the detached, inclusion-containing epithelial cell 
would act like a chlamydial “cluster bomb”, allowing delivery of a concentrated 
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inoculum over a relatively long distance and increasing the possibility of a “hit” if the 
host cell ruptured near the genital epithelial cell layer. More importantly, this mechanism 
may also help to explain how the chlamydiae ascend the genital tract from the initial site 
of infection in the cervix to the fallopian tubes in the female patients.  
 
 
 
 
Figure 5.1 Potential roles of nectin-1 down-regulation and PMNs in C. trachomatis 
dissemination within the host genital tract. Red dots represent EBs; grey circles represent 
RBs.  
 
 
Another interesting possibility is that nectin-1 may facilitate chlamydial entry and 
that down-regulation of nectin-1 may be used by the chlamydiae to reduce the possibility 
of subsequent infection of the same cell by other chlamydiae. This would be analogous to 
viral interference, a phenomenon defined as protection of host cells against subsequent or 
re-infection by similar viruses, conferred as a result of prior infection with a different 
virus. One common mechanism of viral interference occurs when a virus down-regulates 
its receptor after infecting a host cell. The possibility that chlamydiae use nectin-1 down-
regulation to reduce subsequent infection of the same cell with other chlamydiae is 
supported by our and others’ observations. In our study, more infectious chlamydiae are 
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produced from C. trachomatis-infected CHO-necin-1 cells than from the other CHO cell 
lines, even in the absence of HSV co-infection (Fig. 4.4). One possible explanation for 
this observation is that chalmydiae enter cells that have nectin-1 (like HeLa and CHO-
nectin-1) more efficiently than they enter cells that don't have nectin-1. The chlamydiae 
might then down-regulate nectin-1 to reduce the efficiency with which other chlamydiae 
enter. Moulder et al. have found that mouse fibroblasts (L cells) infected with C. psittaci 
(strain 6BC) are resistant to superinfection with the same strain (Moulder et al., 1980). 
Later, they observed that exogenous 14C-labeled C. psittaci does not attach to C. psittaci-
infected L cells at measurable rates. However, when exogeneous C. psittaci chlamydiae 
are centrifuged onto host cell monolayers or added to monolayers pretreated with the 
polycation diethylaminoethyl (DEAE)-dextran, they enter C. psittaci-infected L cells and 
multiply normally (Moulder et al., 1981). Polyacrylamide gel electrophoresis of L cell 
proteins surface labeled with 125I by lactoperosidase-catalyzed iodination revealed 
widespread differences in surface labeling between wild-type and C. psittaci-infected L 
cells. Particularly, the most prominent change is the generalized reduction in intensity of 
labeling of proteins migrating in the molecular weight range from 60kDa to 100kDa. 
These observations suggest that resistance to superinfection is caused by chlamydia-
indcued changes in the structure or cell surface expression of the putative host cell C. 
psittaci receptor(s) (Moulder et al., 1982). As we mentioned in Chapter 2, the molecular 
weight of nectin-1 is about 75kDa, which falls in the range of 60-100kDa. Also, nectin-1 
accumulation starts to significantly decrease in C. trachomatis-infected HeLa cells at 36 
hpi, which is mid-developmental cycle for C. trachomatis serovar E. Although Ridderhof 
et al have shown that prior infection does not influence superinfection with another 
serovar of C. trachomatis during the first 24h following the initial infection (Ridderhof & 
Barnes, 1989), they did not investigate times after 24 hpi. It is, therefore, possible that 
superinfecting chlamydae added after 36 hpi are less able to enter the same cell when 
nectin-1 is significantly degraded. This possibility assumes that nectin-1 is actually 
required for efficient chlamydial entry. Because there are several other possible 
explanations for our observation, defining any role of nectin-1 in chlamydial entry will 
await future experiments. 
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In Chapter 4, we focused specifically on identifying the co-receptor that HSV 
exploits to drive C. trachomatis to enter a persistent state. Previous data from our 
laboratory and observations from other investigators strongly suggest that nectin-1 has 
the most potential for triggering HSV co-infection-induced chlamydial persistence. First, 
both HVEM and nectin-1 serve equally well as co-receptors for HSV-1 and HSV-2 entry 
(Spear, 2004). In contrast, nectin-2 primarily mediates entry of HSV-2 and 3-O-S-HS 
only facilitates HSV-1 entry (Spear, 2004). Therefore, our previously published 
observation that both HSV-1 and HSV-2 are capable of inducing chlamydial persistence 
(Deka et al., 2007) greatly diminish the possibility that either nectin-2 or 3-O-S-HS 
deliver the persistence signal. Thus, HVEM and nectin-1 are the strongest candidates for 
triggering persistence. Second, although HVEM cDNA was originally isolated from a 
HeLa cell library, Montgomery et al have shown that HVEM is probably not the primary 
receptor for HSV entry into HeLa cells in that anti-HVEM serum only had marginal 
effects on the entry of HSV-1 into HeLa cells (Montgomery et al., 1996). Last, 
unpublished data by Vanover et al. from our laboratory have shown that non-crosslinked 
HSV-2 gD:Fc fusion proteins interaction with HeLa cells did not stimulate chlamydial 
persistence. However, when chlamydiae-infected HeLa cells were exposed to 
immunoglobulin cross-linked gD:Fc fusion proteins, the developing chlamydiae became 
persistent (Vanover, 2009b). It has been reported that the dimerizing of nectins is 
required for nectin trans-interaction induced downstream cell signaling cascades (Ogita 
& Takai, 2006a). Perhaps cross-linking gD:Fc fusion proteins increases receptor 
aggregation and thus, increases the efficiency of downstream cell signaling. Collectively, 
these data suggest that, of the 4 known co-receptors, nectin-1 is the most likely candidate 
for stimulating persistence in this system.  
 
The goal of the experiments presented in Chapter 4 was to test the hypothesis that 
nectin-1 is required for HSV co-infection-induced chlamydial persistence. First, because 
previous data from our laboratory indicated that HSV co-infection triggers chlamydial 
persistence in both HeLa and HEC-1B cells (Deka et al., 2007), we ascertained which 
HSV co-receptors were expressed in these two cell types. Importantly, both Western 
blotting and RT-PCR analyses demonstrated that HeLa and HEC-1B cells express nectin-
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1 and nectin-2, but not HVEM (Fig. 4.1a,b). Second, co-infection studies in C. 
muridarum revealed that a significant decrease in chlamydial infectivity occurs in co-
infected cells when HSV-2 is added at 6h and 12h, but not at 24h post-chlamydial 
infection. Additional studies demonstrated that there is a nearly 68% reduction in host 
cellular nectin-1 by 24 hours post-C. muridarum infection (Fig. 4.2b,c). These data 
suggest that HSV co-infection does not interfere with chlamydial development in the 
absence of nectin-1. Third, co-infection studies in HeLa cells with C. trachomatis and co-
receptor-specific HSV-1 mutants indicated that parental strain HSV-1 KOS/FRT-gDwt 
and the three HSV-1 mutants HSV-1 KOS/FRT -gDG43P, -gDQ27P, and -gDA3C/Y38C all 
drive developing chlamydiae to become persistent (Fig. 4.3a,d). β-gal assays further 
demonstrated that the only co-receptor usage that the parental strain and the three mutants 
share is nectin-1 (Fig. 4.3b,c). Last, we determined that HSV attachment/entry using the 
nectin-1 co-receptor alone is sufficient to stimulate C. trachomatis to enter persistence 
using co-receptor-deficient CHO cell lines (Fig. 4.4). The results demonstrated that HSV-
1-induced reduction in infectious EB production is observed in HeLa cell controls and 
CHO-nectin-1 cells, but not in CHO-C8, CHO-HVEM and CHO-nectin-2 cells. Although 
our results demonstrated that HeLa cells and HEC-1B cells do not express HVEM, it is 
possible that the expression of HVEM is below our detection level. However, the fact that 
CHO-nectin-1 cells support persistence during co-infection while CHO-HVEM cells do 
not provides very strong evidence that HSV interaction with nectin-1 triggers viral co-
infection-induced persistence. It is especially important to point out that HSV-1 enters 
and produces progeny virions in both CHO-nectin-1 and CHO-HVEM cells, but 
chlamydial infectivity is decreased only when nectin-1 is present. These data suggest that 
co-infection induced persistence specifically results from HSV gD/nectin-1 interaction 
with nectin-1, rather than from events that occur during or subsequent to virion entry. 
Overall, these observations confirmed that nectin-1 is indeed required for HSV co-
infection-induced chlamydial persistence.  
 
Studies by Vanover et al. demonstrated that HSV-2 co-infection-induced 
chlamydial persistence is not mediated by any currently known persistence inducer or 
anti-chlamydial pathway (Vanover et al., 2008), suggesting a novel anti-chlamydial 
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pathway might be activated during HSV co-infection. As mentioned before, co-infection 
of HeLa cells with either replication incompetent HSV-2uv or with replication-competent 
HSV-2 in the presence of cyclohexamide continues to drive C. trachomatis to enter a 
persistent state, suggesting that productive HSV replication is not required and that 
events during HSV attachment and/or entry are sufficient to stimulate chlamydial 
persistence (Deka et al., 2007). Further, co-incubation of either fixed, HSV-2-infected 
inducer cells or recombinant HSV gD protein with viable, C. trachomatis-infected 
responder cells suppresses infectious EB production and stimulates the formation of 
abnormal RBs. These data suggest the events that occur during viral attachment, instead 
of viral entry, are sufficient to provide stimulus to alter C. trachomatis development 
(Vanover, 2009b). HSV attachment to host cell occurs in several consecutive steps and 
involves viral glycoproteins binding to their cognate host cell receptors/co-receptors 
(Spear, 2004). It is known that HSV/host cell surface interactions activate several host 
cellular signaling cascades. Therefore, it is possible that HSV binding to host cell 
receptors/co-receptors could stimulate chlamydial persistence by activating cellular 
signaling pathways that have negative effects on chlamydial development.  
 
A number of studies have demonstrated that HSV triggers anti-viral pathways via 
Toll-like receptors (TLRs), important critical mediators in generating innate immune 
responses against viral pathogens (Aravalli et al., 2005; Kurt-Jones et al., 2005; Pyles et 
al., 2002). This information raises the possibility that stimulation of anti-viral signals 
during co-infection could have anti-chlamydial effects. HSV gB is reported to be the 
major glycoprotein responsible for inducing TLR-linked anti-viral transduction cascades 
in host cells (Aravalli et al., 2007; Kurt-Jones et al., 2005). However, unpublished data 
from our laboratory indicate that specific antibody neutralization of HSV gB, gC, or gH 
is not able to restore chlamydial infectivity during co-infection. Further studies by 
Vanover et al. demonstrate that co-incubation of recombinant HSV gD protein with C. 
trachomatis-infected HeLa cells induces persistence, demonstrating that HSV gD 
interaction with the host cell surface is sufficient to alter the chlamydial developmental 
cycle (Vanover, 2009b). Notably, IFN-β is one of the first genes activated by HSV-
induced TLR signaling (Schneider et al., 2004). However, semiquantitative RT-PCR 
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studies demonstrate that IFN-β mRNA is not expressed during co-infection (Vanover et 
al., 2008). Finally, the data presented in Chapter 4 demonstrate that HSV co-infection 
inhibits the chlamydial developmental cycle in nectin-1-expressing but not in control 
CHO-C8 cells. Since the CHO control cells and CHO-nectin-1 cells are identical, except 
for the presence or absence of nectin-1, it seems unlikely that the observed effect is TLR 
mediated. Therefore, collectively, these observations indicate that HSV interaction with 
TLRs is not the mechanism underlying the phenomenon of co-infection-induced 
persistence.  
 
Currently, our data indicate that nectin-1, a co-receptor that interacts with the 
HSV envelope gD, is required for triggering chlamydial persistence during co-infection. 
As a member of Immunoglobulin superfamily and an important component of AJs, when 
stimulated, nectin-1 activates the cell signaling molecule Cdc42 through c-Src. The 
activation of Cdc42 and c-Src further cause the activation of the small G protein, Rac. 
Activated Cdc42 and Rac then selectively induce activation of c-Jun N-terminal kinase 
(JNK), but not p38 MAP kinase or extracellular signal-regulated kinase (ERK) (Takai & 
Nakanishi, 2003). The JNK pathway is involved in important cellular events such as 
apoptosis and cell growth (Sakisaka & Takai, 2004). Eventually, activated Cdc42 and 
Rac are involved in regulation of cell-cell adhesion, gene expression and cell polarization 
(Takai & Nakanishi, 2003). Interestingly, temporarily activated Cdc42 and Rac1 have 
been observed at 15 and 30 min after HSV-1 infection of MDCK canine kidney cells 
(Hoppe et al., 2006). It is very tempting to envision that the HSV/nectin-1 interaction-
activated chlamydial persistence response is transmitted through the Cdc42/Rac1 
signaling pathway. However, active GTPase pull-down assays indicate that Cdc42 is not 
activated in co-infected HeLa cells (Fig. S4.2), suggesting this anti-chlamydial response 
is likely mediated through another, as yet uncharacterized, nectin-1-activated host 
signaling pathway. In addition, nectin-1 has at least one natural endogenous ligand: 
nectin-3. It is, therefore, possible that interactions between nectin-1 and nectin-3 could 
also trigger anti-chlamydial pathways causing persistence in the absence of co-infection. 
Thus, investigating the interactions between nectin-1 and nectin-3 might provide a clue 
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regarding which signaling pathway is stimulated and if it activates an anti-chlamydial 
response.   
 
Several studies demonstrate that HIV or human cytomegalovirus (HCMV) 
binding of viral glycoproteins to the host cell surface is sufficient to induce a Ca2+  influx 
into the cells (Alfano et al., 1999; Keay et al., 1995; Keay & Baldwin, 1996; Liu et al., 
2000). Cheshenko et al. recently reported that the calcium-signaling pathway is also 
rapidly activated, with an increased [Ca2+] in the cytosol, after exposure to HSV 
(Cheshenko et al., 2003). They further proposed that a signal is transduced after 
interactions between heparan sulfate proteoglycans and gC or gB, as well as engagement 
of HSV co-receptors by gD. The transduced signal in turn activates the inositol-1,4,5-
triphosphate (IP3) pathway, leading to a rapid increase in [Ca2+]. The increased [Ca2+] 
may further promote phosphorylation pathways, facilitating viral penetration and/or the 
transport of incoming viral capsids to the nucleus (Cheshenko et al., 2003).  Calcium 
signaling has been shown to be important for C. trachomatis intracellular survival. For 
example, type III secretion systems (T3SSs) are unique mechanisms that Gram-negative 
bacteria use to modulate the host cell environment by delivering bacterial effector 
proteins into the host cell. Studies show that low calcium enhances the induction of 
T3SSs in C. trachomatis (Jamison & Hackstadt, 2008). Shainkin-kestenbaum et al. also 
reported that the growth of C. trachomatis is inhibited by addition of calcium antagonist 
verapamil (Shainkin-Kestenbaum et al., 1989). It is possible that fluctuation of host 
cellular calcium levels stimulated by HSV gD/nectin-1 interaction may play a role in C. 
trachomatis intracellular life. Therefore, development of chlamydial persistence by a 
mechanism that acts via triggering calcium-signaling pathways during co-infection could 
be a possibility.  
 
Other possible signaling pathways involved in induction of persistence in C. 
trachomatis/HSV co-infected cells include the NF-kB and the JAK/STAT signaling 
pathways. Both HSV-1 gD and UV-inactivated virions are able to stimulate NF-kB 
activity from 1-3 hpi (Amici et al., 2006; Teresa Sciortino et al., 2007). HSV infection 
can cause down-regulation of the JAK/STAT signaling pathway by inducing host cells to 
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express SOCS3 (Yokota et al., 2005). However, further experimental examination is 
necessary to determine whether these signaling pathways are required for co-infection-
induced persistence. Of course, it is always possible that some unknown signaling 
pathways are activated by attachment of HSV that in turn cause the induction of 
chlamydial persistence. It is also possible that several activated host signaling pathways 
may work together to negatively affect developing chlamydiae. In the future, we plan to 
screen HSV-infected as well as gD-co-incubated HeLa cells using commercially 
available phospho-protein-specific antibody microarrays. Once we have a more global 
view of the host signalling pathways activated by HSV and gD-host cell interaction, 
specific pharmacologic, dominant-negative and RNAi inhibitors of those pathways will 
be used to determine which might be involved in this response. Thus, we hope ultimately 
to determine which signaling pathway is responsible for viral co-infection-induced 
chlamydial persistence.  
 
As mentioned before, HSV and C. trachomatis are two of the most common STD 
agents in the United States and co-infection with HSV and C. trachomatis has been 
observed clinically.  Published data from our laboratory demonstrate that HSV-2 super-
infection of C. trachomatis serovar E-infected human genital epithelial cells profoundly 
alters the chlamydial developmental cycle, driving developing chlamydiae to enter 
persistence. Induction of chlamydial persistence by HSV-2 co-infection has significant 
implications for pathogenesis. Persistent chlamydiae are refractory to killing by anti-
chlamydial drugs, enhancing the likelihood that an individual will experience prolonged 
inflammation of the genital tract and thus increasing the possibility for development of 
severe disease sequelae such as pelvic inflammatory disease and ectopic pregnancy. 
Therefore, it is possible that the severity of the inflammatory response caused by HSV-
2/C. trachomatis co-infection might be even higher than that in an individual infected 
with C. trachomatis alone. Most of the morbidity associated with chlamydial infections is 
due to complications arising from the infection, which are thought to be due, at least in 
part, to release of inflammatory mediators from infected cells. Thus, any stimulus that 
increases release of these compounds might enhance disease pathology. Numerous 
membrane blebs have been observed in HSV/C. trachomatis co-infected cells. The 
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presence of membrane blebs has been associated with release of chlamydial LPS from 
persistently infected cells (Karimi et al., 1989; Wyrick et al., 1999). Although chlamydial 
LPS is less potent than that of other Gram-negative bacteria, it still has the capacity to 
enhance the host inflammatory response (Ingalls et al., 1995). HSV-2 co-infection also 
increases the accumulation of chlamydial immuno-stimulatory antigen cHSP60 (Deka et 
al., 2006).  Increased cHSP60 production would be predicted to result in an increase in 
inflammation that in turn will lead to an increase in tissue damage. An increase in tissue 
damage implies an increase in the complications resulting from chlamydial infection.  
 
Given that productive HSV replication generally kills the host cell, co-infection 
induced chlamydial persistence may seem to have little in vivo relevance. However, data 
from our laboratory demonstrate that productive viral replication is not required for the 
induction of chlamydial persistence (Deka et al., 2007). It is estimated that about 50-200 
defective virions are released for every replication competent virion produced (Roizman, 
2001b). Thus, there may be numerous non-viable viral particles able to attach and enter in 
vivo. Because these defective virus particles are incapable of productive replication, lysis 
of the host cell does not occur. Because only HSV gD is required for triggering 
chlamydial persistence (Vanover, 2009b), attachment of defective virions or soluble gD 
protein to C. trachomatis-infected cells could stimulate persistence without killing the 
host cells. This implies that the persistent chlamydiae could survive within co-infected 
host cells and contribute to pathogenesis in vivo. As a result, persistence induced by 
defective virions is likely of higher in vivo relevance in co-infected individuals than that 
induced by replication-competent virions. More importantly, these exposure conditions 
are more likely to accurately mimic stimulation of the anti-chlamydial pathway by 
existing endogenous host ligands than does co-infection with replication-competent HSV. 
If nectin-1 binding to its endogenous ligands, like nectin-3, can indeed induce chlamydial 
persistence, this response is likely to have tremendous in vivo significance because it 
would be expected to occur in all chlamydia-infected individuals, not just those co-
infected with HSV. 
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The possibility that nectin-1 interaction with endogenous host nectin-1 ligands 
also opens up a fascinating alternative explanation for the nectin-1 down-regulation 
observed in both C. trachomatis- and C. muridarum-infected cultures. Previously, we 
hypothesized that nectin-1 diminution might facilitate chlamydial dissemination in the 
genital tract or serve as a mechanism by which the chlamydiae interfere with re-infection 
of the host cell. Although both alternatives are still quite possible, another hypothesis 
suggested by the data in Chapter 4 is that the chlamydiae degrade nectin-1 to evade 
nectin-1-mediated inhibition of the developmental cycle. This opens up the even more 
exciting possibility that nectin-1 and other endogenous host factors might tightly regulate 
chlamydial development in the host cell. Although this is an almost entirely unexplored 
facet of chlamydia-host interaction, it is not without precedent in the STD field. The 
replication cycle of Human Papilloma Virus (HPV) is closely regulated by interactions 
between viral oncoproteins and host cell factors. During HPV infection, viral genomes 
are coordinately replicated along with the cellular DNA. Upon cell division, viral DNA is 
partitioned to two daughter cells. One daughter cell will remain undifferentitated, serving 
as a reservoir for continued infection. The other daughter cell will detach from the basal 
layer and differentiate in the suprabasal epithelium (Longworth & Laimins, 2004). In 
normal uninfected epithelia, cells exit the cell cycle once they leave the basal layer. 
However, in infected cells, expression of the early viral oncoproteins E6 and E7 enables 
these differentiating cells to remain active in the cell cycle. The E6 mainly interacts with 
the tumor suppressor p53, resulting in ubiquitination and subsequent degradation of p53 
through the recruitment of the ubiquitin ligase E6-AP (Huibregtse et al., 1991).  p53 
regulates the expression of proteins involved in cell cycle control, including the cyclin 
kinase inhibitor p21 (Ko & Prives, 1996). When DNA damage occurs, p53 becomes 
activated and induces expression of p21, leading to cell cycle arrest and apoptosis (Ko & 
Prives, 1996). Via binding E6 to p53, HPV overcomes the proapoptotic activites of p53 
and allows for cell cycle progression (Huibregtse et al., 1991). E7 also inactivates and 
induces the degradation of retinoblastoma protein (pRB), a cell cycle regulatory protein 
required for the G1/S transition and DNA synthesis (Cheng et al., 1995). The abrogation 
of pRB allows productive viral replication in differentiated suprabasal cells (Chellappan 
et al., 1992). In this manner, HPV maintains a productive, disseminating infection in the 
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differentiated epithelial cells and establishes a reservoir of infection in the 
undifferentiated basal cells. Like HPV, C. trachomatis may use nectin-1-induced 
signaling to regulate productive and chronic genital infection. Investigating the 
relationships between nectin-1 and other endogenous host factors may reveal unknown, 
compelling aspects of chlamydia-host cell interaction.  
 
At the present time, the major problem of the chlamydial research field is that 
there is no workable genetic system for transformation and mutagenesis of the chlamydial 
genome. Thus, it is not feasible to apply genetic approaches that are currently used for 
other organisms. In addition, the obligate intracellular nature of these organisms makes 
research on them even more challenging. However, previous persistence studies have led 
to important findings in chlamydial biology and pathogenesis. For example, experiments 
examining the effect of IFN-γ on chlamydial development have led to the identification 
of an important underlying mechanism that helps control chlamydal infection in vivo. 
Similarly, data from our tissue culture model of HSV-2/C. trachomatis co-infection have 
potentially uncovered a novel host cellular response that limits chlamydial development. 
Future investigations on the underlying mechanisms that drive developing chlamydiae to 
enter persistence will provide detailed information of this anti-chlamydial pathway and 
will allow us to evaluate its contribution to chlamydial pathogenesis and host defense in 
vivo. Such investigations will also reveal new and compelling facets of chlamydia-host 
cell interaction and will hasten development of in vivo models of polymicrobial sexually 
transmitted infections.  
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6. Sun, J., Lajoie, D., Stead, C., Shell, S., Vanover, J., Kintner, J., Schoborg, R.  
ChEAP:  a novel elementary body-associated chlamydial protease. The 22nd 
Annual ETSU Student Research Forum, March 31, 2006. Poster presentation.  
 
Seminar: 
 
1. Partial characterization of a Chlamydia trachomatis elementary body-
associated protease: a cautionary tale for protein expression analysis. 2. The host 
adherens junction molecule nectin-1 is down-regulated in Chlamydia trachomatis-
infected genital epithelial cells. September 2007; James H. Quillen College of 
Medicine, East Tennessee State University, Johnson City, Tennessee. 
 
Honors and Awards: 
 
1. Chlamydial Basic Research Society Graduate Student Travel Award, 2009.  
2. ETSU Biomedical Graduate Student Travel Award, 2009. 
3. Graduate student research grant, ETSU School of Graduate Studies, 2008. 
4. Chlamydial Basic Research Society Graduate Student Travel Award, 2007.  
5. ETSU Biomedical Graduate Student Travel Award, 2007. 
6. First Place in Division II, 2006. The 22nd Annual ETSU Student Research 
Forum. 
 
Membership: 
 
 Chlamydial Basic Research Society 
